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BACKGROUND 
 Attention Deficit Hyperactivity Disorder is a behavioural and  
neurocognitive condition characterized by developmentally inappropriate 
and impairing levels of gross motor overactivity, inattention and 
impulsivity. Brainstem Auditory Evoked Potential (BAEP) is an 
important neurophysiological tool which can be used to assess the 
functional integrity of the auditory pathway and its neurotransmission. It 
has been widely used for the  detection of asymmetrical conduction of 
auditory stimuli in the auditory pathway. Using BAEP, we can easily 
detect the early changes occurring in the auditory pathway in children 
with ADHD and detect hearing impairment which may contribute to 
inattention even before clinical manifestation.   
AIM OF THE STUDY 
· To determine the functional integrity of auditory pathway in 
children with ADHD by recording brainstem auditory evoked 
potential. 
· To assess serum zinc levels in these children. 
· To find the correlation between serum zinc levels and Brainstem 
auditory evoked potential in children with ADHD. 
MATERIALS AND METHODS 
30 boys with ADHD in the age group 6 - 11 years without any 
clinical evidence of hearing impairment were included in the study. 
Controls were age and BMI matched healthy children. Both the controls 
and ADHD children were subjected to BAEP and serum zinc levels were 
also measured. The data were analyzed by Student ‘t’ test. 
 
 
RESULTS 
ADHD  children  showed  significant  prolongation  of  wave  III,  V  
absolute  latencies  and  I-III,  I-V  IPLs  of  BAEP.  The  serum  zinc  levels  
were significantly decreased in ADHD children when compared to 
controls suggesting the contribution of zinc in the pathogenesis of 
ADHD. 
CONCLUSION 
There was significant prolongation of central conduction time in 
ADHD children even though there was no clinical evidence of hearing 
impairment assessed by pure tone audiogram prior to the study. Hence 
BAEP can be utilized as an objective electrophysiological tool to evaluate 
the functional integrity of auditory pathway from the external ear to 
lower brainstem. 
KEY WORDS 
Attention Deficit Hyperactivity Disorder, Brainstem auditory 
evoked potential, Absolute latency, Interpeak latency.  
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1.  INTRODUCTION 
         “The slightest deviation in brain activity can be felt in the body and 
small electrical imbalances can become amplified into bigger health 
problems”  
- Dr. Rodolfo Linas 
           Attention is the patient’s ability to perceive a specific stimulus 
without   distraction by other stimuli (environmental or internal) 
           Vigilance is the capacity to maintain attention over a prolonged 
period (sustained attention) 
           Hyperactivity is the state in which there is increased motor 
activity with aggressiveness, over-talkativeness and uncoordinated 
physical activity. 
          Impulsivity is defined as failure to ignore  appealing stimuli other 
than target stimuli which leads to loss of sustained attention to a 
particular target  task hindering successful completion of that task. 
            Attention is maintained by Ascending Reticular Activating 
System and its diffuse efferent projection onto non-specific thalamic 
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nuclei (intralaminar and midline reticular nuclei) and then to the 
neocortex especially the prefrontal (dorsolateral frontal cortex area 45 
and 46, orbitofrontal cortex area 11 and 47) and anterior cingulate                
(limbic) cortex corresponding to brodmann area 24, 32 and 33. RAS 
sends a strong facilitatory drive to the cortical neurons raising their 
background excitability (EEG activity). 
           The functional importance of reticular formation remained 
unrecognized until 1946 when Magoun and Moruzzi103 found that 
electrical stimulation of ventromedial  part of  medullary reticular 
formation caused inhibition of cortically induced and reflexly produced 
movement. Magoun in 1949 showed that high frequency stimulation of 
midbrain reticular formation produces EEG alerting response and arouses 
a sleeping animal. Damage to this area produces a comatose state. 
Electrical stimulation of posterior hypothalamus also produces arousal. 
The ascending reticular activating system is responsible for the awake 
state recorded in EEG. 
          Jasper  and Hambery66 found  that  stimulation  of   non  specific  
projection system of  thalamus which consists of  midline nuclei, 
intralaminar nuclei, ventralis anterior nuclei and reticular nuclei  resulted 
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in widespread rhythmic activity and concluded that  nonspecific 
projection system of thalamus is the rostral  end of reticular activating 
system(discovered by Moruzzi and Magoun) 
            The reticular formation is the phylogenetically old reticular core 
of the brain  which occupies the central portion of medulla and midbrain 
surrounding the fourth ventricle and cerebral aqueduct. It contains the 
cell bodies and fibres of aminergic systems such as dopaminergic, nor 
adrenergic and serotoninergic systems  and also cholinergic systems and 
project to widespread areas of central nervous system where they 
influence motor functions, consciousness, attention, sleep and 
wakefulness, motivation, emotion, reward processing and addiction. All 
systems in reticular formation are influenced by projections from other 
brain areas and can inturn influence the functions of those areas. Thus 
reticular formation is “THE INTEGRATOR IN CENTRAL 
NERVOUS SYSTEM” 
              The brainstem reticular formation comprises of medullary,  
pontine and midbrain reticular formation. Structurally it is classified into  
1. Neuronal aggregates 
2. Reticular pathways 
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a. Afferent connections 
b. Efferent connections.                                                                                                        
NEURONAL AGGREGATES OF RETICULAR FORMATION 
Nuclei of median column: 
          Lie in the midline and called as raphe nuclei 
Nuclei of medial column: 
          Lie lateral to nuclei of median column and called as magnocellular 
nuclei as these are made of large cells. 
Nuclei of lateral column: 
          Lie lateral to medial column and called as parvocellular nuclei as 
these are made of small neurons. 
Functional neuronal aggregates: 
          They are not anatomical entities but have fairly well defined 
physiological functions. Eg: cardiac, respiratory and vasomotor centres. 
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RETICULAR PATHWAYS 
Afferent connections: 
1. From spinal cord – spinoreticular tract 
2. From cranial nerves – brainstem afferent 
3. From Tectum( superior and inferior colliculi) – tectoreticular tract 
4. From cerebellum – cerebello reticular tract 
5. From basal ganglia directly and indirectly 
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6. Neocortex – corticoreticular fibres from motor and sensory cortex, 
orbital , prefrontal, parietal and temporal lobes, cingulated gyrus 
and collaterals from corticofugal fibres. 
7. Limbic lobe including amygdala and hippocampus. 
Efferent connections: 
1. To spinal cord – reticulospinal tract 
2. To brainstem – reticulobulbar fibres 
3. To cerebellum 
4. To red nucleus, substantia nigra and tectum in midbrain 
5. To thalamus, subthalamic nuclei and hypothalamus 
6. To corpus striatum, neocortex and limbic lobe indirectly through 
thalamus and hypothalamus. 
FUNCTIONS OF RETICLAR   FORMATION 
1. Through functional neuronal aggregates influences respiratory, 
circulatory ,gastrointestinal and  visceral functions.  
2. The descending fibres influence motor control and stretch reflexes, 
sensory modulation and autonomic activity 
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3. The ascending fibres which constitutes the ASCENDING 
RETICULAR ACTIVATING SYSTEM controls  the levels of 
cortical activity(attention, alertness,- wakefulness) and electrical 
activity of the cortex (EEG) 
Reticular Activating System is a complex polysynaptic pathway  
arising from Brainstem reticular formation  which projects to intralaminar 
and reticular nuclei of thalamus which inturn projects diffusely and non-
specifically to wide regions of cortex including frontal, parietal, temporal 
and occipital cortices. 
          Collaterals funnel into ARAS not only from long ascending 
sensory tracts but also from trigeminal, auditory, visual and olfactory 
systems. The complexity of neuronal network and degree of convergence 
abolishes modality specificity and most reticular neurons are activated 
with equal facility by different sensory stimuli. 
NEUROTRANSMITTER SYSTEMS OF RAS 
Dopaminergic system 
             Dopaminergic neurons are located in two anatomically and 
functionally distinct  areas namely substantia nigra and ventral tegmental 
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area. Dopaminergic cell bodies in substantia nigra projects to caudate 
nucleus and putamen and play a role in the control of movement. The 
ventral tegmental area in the rostral midbrain has widespread projections 
to various CNS areas and plays a role in circuitry involved in reward, 
motivation, emotion, impulse control  and decision making. 
Nor-adrenergic system: 
               Neurons using norepinephrine as the principal neurotransmitter 
are clustered in pons next to fourth ventricle in locus coeruleus and also 
scattered throughout the lateral tegmentum of brainstem. Activities of 
these neurons are either tonic (constant and continuous) or 
phasic(increases periodically and temporarily).The main function of these 
neurons is to modulate attention, arousal, mood and pain in conjuction 
with serotoninergic and dopaminergic systems. 
             Tonic firing of noradrenergic neurons contributes to general 
levels of arousal and attention whereas phasic firing helps us to focus 
attention onto a specific task while suppressing distracting stimuli. But 
too much of activation of noradrenergic neurons decreases our ability to 
focus on one specific task. 
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Serotoninergic system: 
             Located in raphe nuclei which is a collection of neurons in the 
midline  along  the  entire  length  of  brainstem  and  spinal  cord  and  
modulates regulation of  mood, appetite, sleep, state of wakefulness, 
modulation of pain and some cognitive functions. 
Cholinergic system: 
             Located in the tegmentum of pons and plays a neuromodulatory 
role by enhancing functioning of synapses. Cholinergic projections to the 
thalamus strengthens the excitatory glutaminergic output from thalamus 
to cortex and plays a role in arousal and motor functions. 
Histaminergic system: 
             Located in tegmentum of midbrain and  functionally related to  
cluster of histaminergic neurons located in the posterior hypothalamus. 
Projections of these neurons play a role in general arousal and alertness. 
              When activity of noradrenaline and serotonin containing neurons 
is dominant, there is reduced level of activity in acetylcholine containing 
neurons in the pontine reticular formation and this activity contributes to 
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awake state. Phasic bursts of  noradrenaline release causes arousal state 
and focusing of attention.                     
         Thus   attention  is mediated  by  a complex interaction of limbic, 
neocortical and ascending reticular activating systems. Damage  to many 
brain areas can disrupt attention. For eg: metabolic disturbances, drug 
intoxication, extensive bilateral cortical damage, bilateral lesions of 
frontal lobe or limbic system. 
          Attention Deficit Hyperactivity Disorder is the most common 
neurobehavioral disorder of childhood affecting school aged children 
characterized by inattention, increased distractibility and difficulty 
sustaining attention, poor impulse control, decreased self-inhibitory 
capacity and motor restlessness inappropriate for that particular age         
( Durston.S) 45. They have poor school performance ( Barkley, RA)19 
due  to  difficulty in focusing their attention  efficiently  and easy 
distractibility (Kennemans JJ 72 et  al)  (Vanderstelt  O  163 et al) (Van 
Mourik Rooster 162 et al) 
          In addition to poor school performance,   they have problems like 
interpersonal relationships with family members and peers and also they 
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have low self esteem. ADHD often co-exists with emotional, behavioral, 
language   and learning disorders.  
          DSM-IV (4th edition of American Psychiatric Association’s  
Diagnostic  and  statistical manual) states that the prevalence of ADHD is 
5-8%  (Polanczyk G 115 et al)  and  identifies three subtypes of  ADHD 
according to  (Chhabildas N35 et al) namely                                                             
1. Predominantly inattentive type (30%)  
2. Hyperactive-impulsive type(9%)   
3. Combined type(61%)  which is the commonest type.  
        ADHD is 3-4 times more common in males (9.2% in males and 
2.9% in females), but the inattentive subtype is more common in females.  
           There is no single causal factor in the aetiology of ADHD. Genetic 
and environmental factors acting during foetal and postnatal  
development  such as maternal smoking and toxins such as lead  may 
play a role. It commonly occurs following damage to CNS (prematurity, 
TBI) ,toxin exposure or as a sequelae of CNS infection. Attention is 
mediated by multiple neuronal circuits involving many neurotransmitters   
and   so it is difficult to identify the exact deficit in ADHD(Solomon 
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M138 et  al).  Morphologic  and functional brain dysfunction  including  
moderate reduction in size of  dorsolateral prefrontal cortex,  corpus 
callosum, basal ganglia  and  cerebellum(Makris N 90 et al)  and  
hypoperfusion of frontal-striatal dopamine pathways may be 
implicated(Sillitoe RV 137 et al) 
           Molecular genetic studies reveals strong genetic component such 
as abnormalities in dopamine transporter gene, norepinephrine transporter 
gene and choline transporter gene. Patients with predominantly   
inattentive ADHD had changes in norepinephrine transporter gene , 
predominantly hyperactive-impulsive type had altered  dopamine 
transporter gene and combined type had altered choline transporter gene. 
Alterations in Dopamine Transporter Gene (DAT1) and D4 Dopamine 
Receptor Gene (DRD4) are more likely to have functional significance 
(Faraone SV49 et al).  
Evoked potentials are electrical potentials recorded in response to 
an external stimulus which may be visual, auditory or somatosensory. 
Brainstem Auditory Evoked  Potential  is produced by presenting  
auditory stimuli in the form of clicks to the ear which results in sequence 
of waveforms which are recorded by surface electrodes placed over the 
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scalp. These waveforms are specific for different structures in the 
auditory pathway and so provides specific localization of  pathology .                                                                                           
               Brainstem Auditory Evoked Potentials are markers which 
provide precise information about the delay in the transmission of 
auditory impulses from the periphery to the brainstem (Hood LJ 1998)61.  
BAEP in the first 10 milliseconds (Early Latency Response) provides 
information about the functional integrity of the auditory pathway  from 
the vestibulo-cochlear nerve upto midbrain inferior colliculus.(Jacobson 
J.T.1985)65 
Brainstem Reticular Activating  system   is responsible for 
formation of evoked potentials and neurotransmitter imbalance in the 
fronto-striatal network  which is the hallmark of ADHD  will lead to 
changes in the amplitude and latency of waveforms of  BAEP. It acts as 
an important neurophysiological tool for assessing the delay in 
transmission  of  auditory  impulses  and    assists  in  the  early  diagnosis  of  
ADHD. 
           Zinc is a cofactor for metabolism of many neurotransmitters and 
fatty acids.  It is necessary for 100 different metalloenzymes and complex 
metal enzymes (Arnold LE, Pinkham SM  et al) 13 (Toren P et al)161. It 
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also regulates dopamine metabolism which is involved in the 
pathogenesis of ADHD. Dopamine transporter has an endogenous zinc 
binding site and zinc acts as a potent non-competitive blocker and 
prevents dopamine binding to the dopamine transporter and thus 
increases the extracellular availability of dopamine by decreasing its 
degradation (Lepping P. Haber M)82 
               Published reports of the role of zinc in ADHD shows low levels 
of   zinc  in  serum,  red  cells,  hair,  nails  and  urine  of   affected  
children(Arnold LE, Di silvestro RA) 11. Zinc can be considered as an 
adjuvant in treating ADHD along with approved pharmacological 
stimulant therapies (Akhondzadeh S et al)4. 
           Hence considering these above factors,the present study was 
undertaken  to evaluate the functional integrity of auditory pathway in  
children  with ADHD by performing  BAEP  and to find out the role of 
zinc  in  the  pathogenesis  of  ADHD children  by   comparing   serum zinc  
levels in  normal children and children with ADHD. 
 
 
 Review of Literature 
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2.  REVIEW OF LITERATURE 
Attention Deficit Hyperactivity Disorder is a behavioral and 
neurocognitive condition characterized by developmentally inappropriate 
and impairing levels of gross motor over activity, inattention and 
impulsivity (APA 2000 ) which results in deficits of executive functions. 
It involves impaired ability to plan a work and to execute that plan. The 
prevalence of ADHD has been increasing in the recent years probably 
due to formation of nuclear families rather than joint families and also 
poor parenting techniques. 
         BAEP is a neurophysiological test which can be used to assess the 
integrity of auditory pathway and to localize defective neurotransmission 
in the pathway and can be used to identify hearing impairment in ADHD 
which may contribute to attention deficit in these children. Only few 
BAEP  studies  have  been  reported  in  ADHD  children  and  these  studies  
have shown increase in latency of   BAEP waves and so with this 
background ,  the present study has been taken up to assess the integrity 
of auditory pathway and its neurotransmission in ADHD children. 
       As several researches now-a-days point out to nutritional factors 
influencing mental health, the present study is aimed at measuring serum 
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zinc levels in children with ADHD to identify if zinc deficiency has 
played a role in the pathogenesis of ADHD.  
ATTENTION DEFICIT HYPERACTIVITY DISORDER 
Early in the mid-nineteenth century the problems of inattentiveness 
and overactivity in children were recognized by Heinrich and Hoffman 
(struwwel peter 149 et al) in the moralistic children’s book Slovenly 
Peter which featured the characters Fidgety Phil and Harry. In 1902, 
ADHD was discovered by George Still (Still. G145 et al) as the behavioral 
sequelae of viral encephalitis called as Still’s disease. He described about 
the overactivity and impulsivity of these children and he believed to have 
a combination of organic and environmental factors resulting in lack of 
inhibitory control(impulsivity) and inattention in these children. 
            After the influenza pandemic in 1919 to 1920, children who 
survived developed severe behavioral problems similar to that described 
in Still’s monograph. The flu survivors were thought to have organic 
brain damage and so the condition was termed as Minimal Brain Damage 
Syndrome. 
               In 1937, C.Bradley published  a  report that d,l-amphetamine 
reduced restlessness and improved concentration in children with 
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behavior problems  in a residential treatment centre. This concept was 
ignored for about 30 years when Keith Conners and Leon evaluated the 
efficacy of d- Amphetamine in a double blind placebo controlled trial for 
children with learning disability and behavior problems. In the early 
1960’s the condition was renamed as Minimal Brain Dysfunction which 
implied specific anatomic location which was not proved till then. 
Genesis of the terms ADHD and Hyperkinetic Disorder 
Initially ICD-9 (International Classification of Diseases and 
Related Health Problems) and DSM (Diagnostic and Statistical Manual 
of Mental Disorders) adopted the same descriptive definition for this 
condition termed hyperkinetic syndrome of childhood. This term believed 
that hyperactivity was the core feature of this disease. But further 
research suggested that the main disability associated with this condition 
is the difficulty in maintaining sustained attention and impulsivity 
whereas motor overactivity is only secondary. This resulted in 1980 
version of APA (American Psychiatric Association) classification which 
renamed  the  condition  as  Attention  Deficit  Disorder  (ADD).  This  
included three symptom categories as diagnostic criteria in which three 
out of five inattentive symptoms, three out of six impulsive symptoms 
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and two out of five overactivity symptoms was proposed. Based on this 
three  subtypes  of  ADD  were  described  namely  Attention  Deficit  
Hyperactivity Disorder, Attention Deficit Disorder without Hyperactivity 
and a Residual type that included adults with ADD symptoms but no 
longer met childhood ADHD criteria. 
In 1987, DSM version named as DSM III-R, which included a 
single criterion list requiring 8 of the 14 possible symptoms of 
hyperactivity, impulsivity and inattention was published. Duration 
criteria was added stating that the behavior should be present since age 7 
years and for atleast 6 months. This version had no sub groups. 
In 1994, APA published the 4th edition of DSM and in 2000, a Text  
Revision, DSM IV-TR  which is the current version. 
Diagnostic Definition of ADHD 
          There are two main approaches to define disorders of 
inattentiveness, hyperactivity and impulsiveness namely DSM IV-TR 
(APA 2000) which recognizes the term   “Attention Deficit Hyperactivity 
Disorder” and ICD-10 (WHO , 1992) which uses the term “Hyperkinetic 
Disorder”.  Both  are  based  on  the  same descriptions  of  behavior  but  the  
items are weighed differently (swanson, sergeant, Taylor et al) 150. 
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Hyperkinetic Disorder (ICD – 10) requires all three components to 
be present and that the diagnostic criteria must be met in more than one 
situation(both home and school) and excluded by presence of other 
disorders such as autism and anxiety states. 
ADHD (DSM-IV)  is divided into  3 subtypes 
1)  Combined type  
2) Inattentive type  
3) Hyperactive/impulsive type 
With five main diagnostic criteria 
1.  Onset before 7 years. 
2.  Duration greater than 6 months. 
3.  An 18- item symptom list of which 6 of 9 inattention (or ) 6  of 9 
hyperactive/impulsive symptoms have persisted for atleast 6 months to a 
degree that is maladaptive and inconsistent with developmental level. 
4.  Some impairment in two (or) more settings. 
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5.  Symptoms that donot occur exclusively during the course of 
pervasive developmental disorder, schizophrenia or other psychotic 
disorder.  
The practical consequence of   these different diagnostic 
definitions is that the ICD-10 category of Hyperkinetic Disorder is a 
subgroup of ADHD described in DSM IV criteria (Santosh, 
Taylor,Swanson  et al) 130. Diagnosis is usually clinical  using history  
taken from parent and atleast one other adult such as teacher or coach. 
There is no simple objective test such as blood test to diagnose ADHD.  
EPIDEMIOLOGY 
ADHD is the most common childhood psychiatric disorder 
affecting 5- 12% of children worldwide.  Polancyzyk et al 115 estimated 
this prevalence using a meta-analysis which included about one lakh 
patients and 100 articles.                 
Prevalence rates vary in various cultural settings according to 
diagnostic criteria used to classify the disease and reported in a range of                                         
1   -20%.  (Jensen 2005) 67 .  The  male  female  ratio  is  2:1  in  community  
samples in contrast to 5:1 or 9:1 in mental health clinic sample (Szatmari 
P et al) 151.  Boys with ADHD have higher rates of  disruptive behavior 
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(breaking rules) such as interference with teacher and classmates, 
distractability and both physical and verbal aggression than females 
(Abikoff 2002)3. Females present more often with less disruptive 
symptoms, more attention problems and problems such as depression and 
anxiety than males with ADHD . Male sex, low socioeconomic status  
and young age are associated with high prevalence of ADHD                      
(Biederman J )26   
Recent studies prove that ADHD symptoms continue into teenage 
and adulthood although previously it was proposed that ADHD 
symptoms wane off as the child reaches adolescence (Pierce EW113 et al) 
In India, few epidemiological studies are available for ADHD 
which report prevalence rates ranging from 10-20% . They have also 
shown that ADHD is more prevalent in boys than in girls. ADHD is more 
prevalent in lower socioeconomic class. (Malhi P, Singh P et al) 91. It is 
also more common in nuclear families and behavioral problems are high 
in children from nuclear families(Verghese A, Beig A)164 
AETIOLOGY 
The aetiology of ADHD is complex and involves interaction 
between genetic and environmental factors during early fetal 
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development  which creates a neurobiological susceptibility  to this 
disorder. The expression of disease is mediated by alteration in different  
neural networks  and neurotransmitters involved in mediating attention 
and executive functions(Sonuga- Barke EJ)140. 
Prenatal, perinatal and post natal factors play a role in the 
pathogenesis of ADHD. Prenatal factors are associated with maternal 
lifestyle during pregnancy such as smoking and alcohol intake  ( Linnet, 
Dalsgaard  et al) 86. 
          Maternal smoking has the strongest evidence among environmental 
factors and it increases the risk for ADHD by 2.7 fold.  
( Milberger S et al) 98. There is a dose- response relationship between 
maternal smoking and ADHD. (Thapar, Fowler, Rice  et al)157.This may 
be due to the effect of smoking on nicotinic receptors which modulate 
dopamine which is involved in pathogenesis of  ADHD(Potter AS, 
Newhouse PA, Bucci)117 .Prenatal exposure to alcohol may lead to 
structural anomaly of cerebellum which is implicated in the pathogenesis 
of ADHD (Coffin  JM  et  al)39.Exposure  to cocaine  may lead to 
increased risk of ADHD(Linares, Singer, Kirchner et al) 85. 
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Seasonal  predilection is associated with some cases of ADHD 
children who are born commonly in the month of September(winter) 
which may due to viral infections triggering the disease in genetically 
predisposed individuals(Seeger G et al).132 Matenal stress during 
pregnancy may lead to ADHD due to increased cortisol secretion in 
stress( Kapoor, Dunn, Kostaki et al)71 
           Perinatal factors  have also been implicated in ADHD. There is a 
two fold increase in ADHD  in low birth weight children(Bhutta, Cleves, 
Casey et al)25. This effect is due to subtle lesions in frontosriatal  
circuit involved in pathogenesis of ADHD ( Carmody, Bendersky, 
Dunn et  al)31. Pregnancy and birth complications have been reported in 
mothers of children with ADHD( Ben Amor, Grizenko, Schwartz et al, 
2005) 21. 
            Post natal factors include social and biological factors. Biological 
factors  include a role for dietary deficiencies.  
             There is an imbalance of essential fatty acids such as omega-3 
and omega-6 fatty acids which has been suggested in the pathogenesis 
(Richardson, Montgomery, 2005et al )119. Iron deficiency has been 
implicated in some cases of ADHD ( Konofal, Lecendreux,Arnulf et al 
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2004 )74.  A  role  for  artificial  food  additives  in  the  aetiology  of  ADHD  
have  been  proposed  in  a  randomized  control  trial  but  remains  
controversial  ( Mccann, Barrett, Cooper et al  2007) 96 . Idiosyncratic 
allergies and specific food allergies have been reported by some parents . 
Exposure to lead is associated with risk of hyperactive and inattentive 
behavior (Levitt M 1999)84. 
             Social factors are also implicated in the aetiology in ADHD. 
Children experiencing parental neglect and abuse may be at increased 
risk of ADHD (Glod and teicher, 1996).52  An English and Roman 
adoptees study has shown that these children were persistently 
hyperactive and inattentive even after adoption into another family before 
the age of 4 yrs (Kreppner, O’Connor & Rutter, 2001)77. 
              Genetic factors play an important role in the pathogenesis of 
ADHD. The mechanism by which they exert influence is not known 
(Asherson, Kuntsi, Taylor 2005)16. Family, adoption and twin studies 
show that ADHD is a highly heritable disorder(Rietveld, Hudziak, 
Bartels et al)120. Siblings of ADHD children show an eight fold increase 
in risk of ADHD (Faraone and Biederman, 2000)48. Biological relatives 
are at more risk than adoptive family members (Sprich, Biederman, 
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Crawford et al) 141. According to twin studies, ADHD is one of the most 
heritable conditions accounting  about   60 to 90% (Thapar A et al)156 
Genes regulating neurotransmitter systems have been proposed to 
be involved in ADHD .Specific genes involved in the pathogenesis of 
ADHD were studied and these studies showed significant pooled effects  
for  three  polymorphisms  of  dopamine  genes,  the  D4  and  D5  
receptors(DRD4 AND DRD5) and the dopamine transporter (Faraone  
et al 2005)49 ( Thapar A et al )156.  DAT 1 and DRD4 are more likely to 
have functional significance out of these. There is no evidence for nor-
epinephrine  gene variants as of now but are under research. But  DAT I 
association has been contradicted in a recent meta analysis( Wohl, 
Purper- Ouakil, mouren et al 2005)169. 
Based on animal knock out models an association of  functional 
polymorphisms of serotonin transporter and receptor genes SLC6A4 and 
HTR 1B with ADHD has been suggested (Faraone et al , 2005)49.  
Genome scan studies on potential alleles for ADHD demonstrate linkage 
of chromosomes 5p13,6q12,16p13,17p11 and 11q22 – 25. 
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GENE ENVIRONMENT INTERACTIONS  
Genes may interact with each other  and with environmental risk 
factors  to increase risk of ADHD  in a non-linear manner so that genes of 
small effect show  disproportionately larger manifestation of the disease 
when interacting with environmental factors (Rutter, Moffitt & 
Capsi)125. 
         Studies show that gene variants such as DRD4 and DAT 1 interacts 
with prenatal substance exposures in specific subtypes of ADHD.  
         Smoking is associated with combined ADHD in genetically 
susceptible children. (Khan, Khoury, Nicholas et al)70. Alcohol 
consumption during pregnancy is also associated with specific 
genes(Brookes, Mill, Guindalini et al)30,   DAT 1 and DRD4 genes   
interacts with season of birth( Seeger, Schloss, Schimidt et al)132. 
PATHOGENESIS OF ADHD 
The pathogenesis of ADHD involves  three main concepts namely 
genetic aetiology, frontostriatal or executive dysfunction disorder and a 
catecholamine disorder. A change in concept of  ADHD from a primary 
hyperactive disorder to an attentional disorder by DSM III R ,highlighted  
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neuro cognitive defects as the core pathology of the disease                      
( Castellanos, Sonuga- barke et al)34. 
            The concept of fronto-striatal/executive function disorder was 
proposed based on the similarities between people with ADHD and  
frontal lobe lesions (Denckla, 2002)42.The circuit  involved in this 
executive cognitive function is the Thalamo – cortico –striatal loop  
which consists of  projections from the dorsolateral prefrontal cortex to 
the caudate nucleus of neostriatum which pass via a complex set of direct 
and indirect basal ganglia pathways through the thalamus and back to the 
prefrontal cortex (Alexander &crutcher  et al, 1990)5.  This  circuit  has  
connections to other regions such as the cerebellum, the parietal cortex, 
the dorsal anterior cingulated cortex, corpus callosum and  the frontal 
motor cortex (Timmann, D et al) 159 (Emond V, Joyal C, Poissant H)47. 
Activity within this circuit is mediated by GABA and glutamate which is 
responsible for the background thalamo-cortical EEG activity which is 
modified by other neurotransmitters such as dopamine, norepinephrine 
and acetyl choline during stimulus related evoked responses and arousal 
mechanisms. 
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The prefrontal cortex functions in thinking and planning              
( Mc.Geer et al, 1987) 95. It is described as attention association area and 
integrates body movements and behavior associated with attaining goals 
(Posner & Peterson1990)116. It operates in focusing the mind on specific 
tasks by screening out distracting sensory inputs in order to concentrate 
on a goal. 
Basal Ganglia are masses of grey matter that lie lateral to the 
thalamus and involved in regulation of motor activity. Thalamus 
communicates with basal ganglia through neurotransmitter dopamine, 
brainstem relays information to basal ganglia via serotonin and acetyl 
choline mediates transmission from cerebral cortex to basal ganglia. 
Basal ganglia is involved in planning of movements and organization of 
goal directed behaviors. Basal Ganglia is found to be less active in 
children with ADHD (Gabrieli, Brewer et al)50 . 
Other than fronto-striatal executive circuit several extra-executive 
circuits have been implicated in the neurobiology of ADHD.  
Toplak, dockstader & tannock 160 et al, 2006 has implicated thalamo-
cerebellar circuits in neural timing and temporal synchrony.  
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Sagvolden, johansen, aase et al.,(2005) 126; SonugaBarke et al(2005)140 
has implicated orbitofrontal – ventral striatal circuitry in reward and 
motivation. 
Banaschewski, Brandeis, Heinrich et al.,200417 has implicated  
posterior parietal network  in attention, orientation and alerting response. 
Anterior cingulate cortex is implicated in affective component  
of ADHD. Thus compensatory networks like insula and cerebellum  
are implicated in lower cognitive tasks in ADHD .(Castellanos FX,  
Lee PP et al)33  
           The evidence of catecholamine (dopamine and nor-epinephrine) 
dysfunction is indirectly shown by three observations. 
1. ADHD symptoms are reduced by DA & NE agonists which act by 
different mechanisms to increase extracellular DA & NE 
(Pliszka,2005)114 
2. There are a number of polymorphisms in gene affecting 
catecholamines especially dopamine(Faraone et al,2005)49 
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3.  Lesions and knock out of genes related to catecholamines in animal 
models produce symptoms that mimics ADHD(Arnsten and 
Li,2005)15. 
The neurotransmitter dopamine is involved in motor control and 
feeling of well being. Dopamine transmission is found to be reduced in 
children with ADHD (Castellanos et al)34 
EVIDENCES FAVOURING FRONTO-STRIATAL/EXECUTIVE 
FUNCTION HYPOTHESIS 
          Performance of children with ADHD is worse than controls in 
cognitive and executive functions such as response inhibition (ability to 
inhibit a response which is already initiated), delay aversion(a preference 
between a small immediate and a large delayed reward), interference 
control, planning and working memory (Huang-Pollock&Nigg)63.  
         Nigg et al, 2005106  conducted a study which showed that half of the 
children with ADHD showed a deficit in atleast one executive function. 
MRI studies in children with ADHD have reduction in brain 
volumes up to 5% involving both gray and white matter. 
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 Castellanos, Lee, Sharp et al33 has shown reduction  particularly 
in the dorsolateral prefrontal cortex and neostriatum (caudate nucleus and 
putamen). 
 Emond.V, Joyal.C & Poissant H et al 47 has shown reduction  in 
volumes of and also corpus callosum ,dorsal anterior cingulate cortex and 
cerebellum. 
Shaw, lerch, Greenstein et al., 2006 133 have shown that cortical 
thinning is especially marked in prefrontal regions associated with 
executive control. 
Shaw  P,  Rabin  C  et  al134 has shown a marked delay in cortical 
maturation in children with ADHD. The delay was associated with 
decreased cortical thickness in all regions of brain, especially Prefrontal 
cortex and right posterior parietal cortex. Children who continued to have 
ADHD symptoms in adulthood had thinner grey matter in the prefrontal 
cortex which persisted. Children who grew out of the disorder showed 
normalization of right posterior parietal cortex thickness which was 
initially thin. 
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Diffusion tensor imaging(DTI) is a modality of MRI which 
provides information about the direction and integrity of neural tracts in 
the brain. 
 D’Agati E, Caserelli et al41 have conducted DTI studies in 
ADHD children and has shown developmental changes such as defective 
myelination in the white matter pathways surrounding basal ganglia and 
cerebellum. These changes cause a decrease in the speed of neural 
communication. 
White matter abnormalities such as reduction in volume has been 
reported in ADHD children. Silk et  al136 2008 in his study in 15 young 
males found white matter abnormalities in several regions underlying 
inferior parietal, occipito-parietal, Inferior parietal and inferior temporal 
cortex.            
Durston, Tottenham, Thomas et al.,(2003) 45 have conducted 
functional MRI ( f MRI ) studies which showed reduced activity in 
ventrolateral and dorsolateral prefrontal cortex and Rubia et al (1999) 124 
has shown reduced activity in neostriatum which includes caudate and 
putamen. 
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PET and  SPECT show dynamic  measures  of  brain  metabolism at  
rest and during cognitive tasks and several studies have shown 
abnormalities in cerebral activation in ADHD with a hypo perfusion in 
frontal and striatal areas. Imaging studies using ligands highly selective 
for dopamine transporter which is involved in the pathogenesis of ADHD 
has shown that there is increase in DAT binding in the striatum of ADHD 
children. 
Volkow ND et al165 has done PET studies showing that 
methylphenidate hydrochloride blocks DAT and the extracellular 
dopamine increase is directly proportional to the level of blockade. This 
leads to increased perception of the external sensory stimuli in ADHD 
children. 
CLINICAL FEATURES 
Hyperactivity 
              This is the increase in activity which does not change with the 
set demands of the situation. So, children with ADHD are more active in 
the classroom and less active in the playground as compared to normal 
children. The level of gross motor activity decreases with age, but 
fidgetiness and inner sense of restlessness continues into adult life. Motor 
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difficulties include problems of sensory motor coordination such as poor 
hand writing, clumsiness and delay in achieving motor milestones. Motor 
impairment is associated in 50% of ADHD children. Motor problems are 
related to abnormalities in structure or function of cerebellum and basal 
ganglia. 
Attentional  Difficulties 
ADHD children show several attentional difficulties. Cognitive 
functions such as problem solving, planning, orientation, alertness, 
response inhibition and working memory are impaired. They exhibit easy 
distractability, inability to sustain attention on a task, failure to follow 
instructions, inability to complete a task without constant supervision and 
forgetfulness in daily routines. Other domains involving affective 
components such as motivation , response inhibition  and delay aversion  
are  also involved (Castenellos et al)34 (Nigg JT et al) 106. 
Impulsivity 
These children engage in dangerous activity, yells out in class, 
interrupts or intrudes on others during games or conversations. Impulsive 
behavior results in trouble with parents, teachers or other children 
resulting in physical or verbal fights. They respond very quickly without 
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thinking leading to decreased academic performance. This is due to 
internal pressure persuading the child to respond quickly. 
Cognitive aspects 
                They have difficulty in time management and donot develop 
internal sense of pace in planning tasks. This poor time sense leads to 
problems in estimating actual difficulty waiting in a line and planning 
how much time a task requires. 
Behavioral aspects 
Children with ADHD lack persistence. They become bored and 
leave games early before they are finished. Other disabilities include 
temper outbursts, mood lability, greater  intra individual  variability of 
reaction time and  cerebellar associated defects in motor timing . 
Comorbidity 
           Considerable comorbidity in children occurs with conduct 
disorder, oppositional defiant disorder, mood and anxiety disorders and 
mental retardation (Biederman et al )27. 
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Course of  ADHD  
Between 30 – 70% of children diagnosed  as ADHD will continue 
to show symptoms as adults. In a study of adult ADHD, both genders had 
manifestation  but  females unlike in childhood situation were in majority 
and had higher rates of depression, anxiety disorders and conduct 
disorder than controls.(Biederman et al 1996)26 
DIAGNOSIS 
Since 1994, the diagnosis of ADHD has been most commonly 
made based on DSM IV criteria. Most children are referred because of 
impairment in academic performance, family or peer relationship. 
Although symptoms of gross motor overactivity declines with age, 
impairment due to inattention and impulsive behavior may continue into 
adulthood as adult ADHD. The presence of psychiatric comorbidity 
increases with age further complicating the clinical picture. ADHD is a 
diagnosis primarily made by history and various rating scales such as the 
Parent Teacher Rating scales for ADHD(Du paulGJ), the SNAP 
(Swanson) and Conner’s revised long form(Conners). Additional 
diagnostic information can come from both positive and negative family 
history. 
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Mental status examination is done to rule out other mental 
disorders.   Physical examination identifies soft neurological signs which 
include non focal motor deficits such as deficits in balance, motor 
planning and control and also deficits in sensory integration. Gustaffson 
et al, 2000 found a significant correlation between soft neurological signs 
and decreased cerebral blood flow measures in the frontal lobes 
bilaterally in children with ADHD. Inquiry about  dietary intake and food 
allergy should also be done. 
Electrophysiological studies such as EEG and Evoked Potentials 
are simple tools which aid in the diagnosis of ADHD. Several studies in 
ADHD children has reported changes which pose them as an important 
diagnostic tool. 
          EEG provide information about the background electrical activity 
of the brain. This study was first done in ADHD patients in 1938 by 
Jasper HH 66, Solomon P, Bradley when they mostly included 
qualitative EEG. With advancement in technology QEEG(Quantitative 
EEG) is used now  not only for diagnostic purposes but also for 
biofeedback to improve attention. 
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           Monastra (2000)102 found that diagnosis of ADHD can be 
accurately made by the use of Q EEG procedures which measures 
electrophysiological activity in specific brain regions . The ratio of slow 
wave to fast wave activity (theta/beta ratio) is a developmental marker. 
Young children have high ratio which declines with age.  
In ADHD children this ratio doesn’t decrease with age and it is 
typically greater during tasks that demand focus. 
Several QEEG studies have been done which have shown high 
theta/beta ratio in areas such as prefrontal cortex which is specifically 
involved in ADHD with high specificity and sensitivity.             
EVOKED POTENTIALS 
Evoked potentials are electrical potentials that occur in a group of 
neurons in response to stimulation of a sense organ which can be 
recorded by surface electrodes over the corresponding cortical areas. EPs 
are reliable measures of objective function of specific sensory pathways. 
They are very sensitive to detect abnormality even in a clinically normal 
subject and are highly specific in localizing the lesion in the particular 
component of the sensory pathway involved.  
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Event Related Potentials (Long latency potentials) 
         These are long latency evoked potentials evoked by endogenous 
stimuli which provide information about brain activity during cognitive 
tasks in response to auditory or visual stimuli and requires subject’s 
attention and cooperation. They have a longer latency and higher 
amplitude and are not influenced by the intensity and frequency of 
stimulus. Due to the use of different types of performance indicators most 
of the studies related to ERP s are difficult to interpret. 
Stimulus Related Potentials(short latency potentials) 
         These are short latency potentials evoked by exogenous stimuli 
which provide information about the integrity of neural pathways and 
neurotransmitter systems involved in interpretation of sensory stimuli 
presented to the individual which may be auditory, visual or tactile 
stimuli and they are independent of subject’s level of attention and can be 
recorded even during sleep or anaesthesia. But they are influenced by 
frequency and intensity of the stimuli as opposed to Event related 
potentials.   
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ADHD and BAEP 
Brainstem Auditory Evoked potentials may provide useful 
information about the integrity of auditory pathway and neurotransmitter 
systems involved in auditory transmission. It has been postulated that 
asymmetrical conduction of acoustic stimuli in the brainstem plays a role 
in  the  pathogenesis  of  ADHD  (Lahat E et al)79. Defective auditory 
transmission may lead to defective attention in ADHD.A few studies 
have been conducted using BAEP in ADHD children and shows increase 
in amplitude and latency of several waveforms showing defective 
auditory transmission. BAEP can be used as a simple and cost effective 
physiological tool to assess auditory transmission.  
              Hannan Azzam et al 56 conducted an ABR study using click 
stimulus as well as speech stimulus and MMN on 15 Arabic speaking 
ADHD children and 15 age matched controls in the child/adolescent 
psychiatry clinic, Ain Shams University and found increased absolute 
latency  of  wave  III  and  inter-peak  latencies  I-III  &  I-V  in  both  ears  in  
33%(5/15) of ADHD children. Abnormal speech ABR was observed in 
87%   (13/15) ADHD children. The peak MMN latencies were prolonged 
with reduced amplitude.MMN component was absent in 40% (6/15). 
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              A Puente et al 2conducted a study in 18 school children 
diagnosed with ADD and compared them with 18 normal school children 
by recording both short latency auditory evoked response and long 
latency auditory evoked response and showed that brainstem conduction 
was significantly abnormal in children with ADHD. He found prolonged 
latencies of waves III & V and prolonged I-III & I-V IPL in ADD 
children as compared to controls. The latency of P300 was increased and 
mean amplitude was significantly decreased in children with ADHD 
compared to controls. He concluded that school children with ADD show 
significant abnormality in both Brainstem Auditory Evoked Response 
and Long Latency Auditory Evoked Response and so these 
electrophysiological procedures involving auditory pathway can be useful 
in diagnosis of children with ADHD. 
Lahat et al79 conducted a study in which he found prolonged wave 
III latency in females and prolonged wave V latency in both males and 
females. There was a prolonged I-III IPL in females and prolonged I-V 
IPL in both male and female subgroups. This result showed disturbance 
in the neural transmission in the auditory pathway. The latency of wave I 
is identical in both study and control groups showing that the abnormal 
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neural conduction in ADHD children is not due to abnormality in inner 
ear or eighth nerve. 
NeelamVaney, MD et al 105conducted a study on 20 male ADHD 
children and 20 age and sex matched controls in the Electrophysiology 
Laboratory of the Department of Physiology, University College of 
Medical Sciences, Delhi and showed that there were no statistically 
significant differences in the absolute peak latencies and amplitude as 
well  as  the  IPLs  of  ABR  waves  in  ADHD  children  as  compared  to  
controls. 
             Schochat E et al131 conducted a study in 21 ADHD children and 
found that all children had normal ABR and normal latency for wave V. 
Some delayed P300 was found, some small and some absent. Among 42 
ears combined 52.38% did not have P300. Medicated group had more 
presence of P300 than non-medicated group. 
          Ana Carla Leite Romero et al9 in his article published in 
Brazilian Journal of Otorhinolaryngology has shown that when long 
latency auditory evoked potentials were measured in ADHD children 
using MMN & P300 there was significant differences in P2 amplitude in 
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LE which was higher for ADHD children and N2 amplitude and latency 
was abnormal in ADHD group. 
         Hilary Gomes et al 59conducted a study to characterize the deficits 
in attention allocation in ADHD children. Findings for Nd, P3b and Ta in 
these children suggest that deficits in auditory selective attention in 
children with ADHD may be attributed to reduced information during 
early auditory processing. Nd waveforms were not elicited in children 
with ADHD and they exhibit significantly lesser auditory responses at 
100ms (Ta).  
             The development of electrophysiological techniques such as EEG 
and Evoked potentials have passed through a series of interesting 
historical aspects after the introduction  of  electrodiagnosis based on 
faradic and galvanic current by Erb in 1861. 
              Richard Caton118, a lecturer at Liverpool, UK had an idea that 
as the nerve impulse flows in and out of the brain, it may be detected at 
the surface and reported the findings in a meeting in British Medical 
Association in 1875. He demonstrated the effects of anoxia and 
anaesthesia on these potentials using optical magnification of movement 
of meniscus in Thompson’s galvanonometer as electronic amplifiers were 
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not available at that time. He described EEG(Background electrical 
activity) as well as cerebral potential changes evoked by sensory 
stimuli(Evoked Potentials) and published his reports in British Medical 
Journal in 1877.   
          In 1929, Hans Berger,  a  German  psychiatrist  was  the  first  to  
record EEG and documented brain waves using two scalp electrodes  
on his own son and named this spontaneous ongoing activity as  
“Des Electrenkephalogram”. 
           In 1939 Davis recorded the first auditory evoked potential but the 
amplitude of this evoked potential was very small and it was George 
Dawson who discovered an innovative method of extracting the evoked 
potential from the ongoing EEG activity. First he used a photographic 
superimposition averaging technique to bring out EP wave form from 
back ground EEG activity and later he used an electronic summation 
technique which subsequently became the computerized averaging 
technique used today. 
            In 1967, Sohmer and Feinmesser were the first to publish ABR 
recorded with surface electrodes in humans and attributed it to brainstem 
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structures and showed that cochlear potentials could be obtained non-
invasively. 
          The concept of far field potential was first developed by Jewett 
and in 1971, Jewett and Williston gave a clear description of human 
ABR wave forms and correctly interpreted the generation of the waves 
from brainstem. This short latency auditory response was first called as 
Jewett bump and now known as BAEP. 
         In 1974, Hecox and Galambos showed that ABR could be used for 
threshold estimation in adults and infants. 
        In 1977, Setters and Brackman published landmark findings on 
prolonged IPL in tumor cases. 
 BRAINSTEM AUDITORY EVOKED POTENTIAL 
BAEP is an objective test of auditory brainstem function in 
response to auditory click stimuli which consists of seven positive waves 
recorded during the first 10 milliseconds after a click stimulus labeled as 
waves I to VII. The synonyms of BAEP include Auditory Brainstem 
Response (ABR), Brainstem Auditory Evoked Response(BAER), 
FIGURE 3.  GENERATORS OF VARIOUS AUDITORY EVOKED 
POTENTIALS 
 
 
AP & CM  - Action potential and Cochlear microphonics 
CN               - Cochlear nucleus 
IC                 - Inferior colliculus 
MGB            - Medial Geniculate Body           
 MLR            - Middle Latency Response 
LLR              - Late Latency Response 
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Brainstem Evoked Potential(BSEP), ABR audiometry, and Brainstem 
Evoked Response Audiometry (Jiang et al) 68. 
              The auditory evoked potential of first 10 millisecond after the 
acoustic stimulus is called the short latency response (SLR). The SLR is 
popularly known as brain stem auditory evoked potentials (BAEP), since 
it records the auditory evoked potential when the auditory stimulus is 
traversing through the brain stem region. The middle latency response 
(MLR) is the transient response that occurs in the 10- 50 milliseconds 
post-stimulus time and the late latency response (LLR) is the response 
recordable in the 50-300 milliseconds post-stimulus period  
(Picton TW et al)112.      
ANATOMICAL AND NEUROPHYSIOLOGICAL BASIS OF BAEP83 
The  sound  pressure  wave  produces  displacement  of  the  tympanic  
membrane which is transmitted to the oval window through the inner 
ossicles. This produces movement of the perilymph (contained in the 
scalavestibuli  and  scala  tympani,  which  are  joined  at  the  apex  of  the  
cochlea by the helicotrema) and then secondarily of the endolymph, 
which is present in the ductus cochlearis or scala media which includes 
the basilar membrane, spiral organ, and the tectorial membrane. The 
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spiral organ contains hair cells that, when displaced by the movement of 
the tectorial membrane, produces auditory potentials. The receptor 
potentials leads to the release of the neurotransmitters, which trigger 
action potentials in the dendrites of the afferent nerve fibers of the 
cochlear nerve. There are 20,000-30,000 hair cells distributed over a 
distance of approximately 31.5mm in the 2.5 spirals of the cochlea.  
High-frequency sounds activate the basal portion of the basilar membrane 
where as low-frequency sounds generate receptor potentials in the apical 
portion of the cochlea. The click, which is the most commonly used 
stimulus to produce Brain stem auditory evoked potentials (BAEPS), 
contains mainly high-frequency components and mainly activates the 
basal portion of cochlea. 
The cochlear nerve neurons are bipolar, situated in spiral ganglia 
and their dendrites go to hair cells and axons to the cochlear nucleus.  
The cochlear nucleus has three sub-nuclei: 
1. Anterior ventral cochlear nucleus (AVCN) 
2. Posterior ventral cochlear nucleus (PCVN) 
3. Dorsal cochlear nucleus(DCN) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
FIG-4  AUDITORY PATHWAY 
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The output of AVCN is through the ventral acoustic striae forming 
the bulk of trapezoid body to terminate in the superior olivary nuclei and 
inferior colliculus. The neurons in the AVCN discharge at short latency 
to acoustic stimuli with a pattern like that of cochlear nerve.  
The output of PVCN mostly goes through the ventral and middle 
acoustic striae to terminate in the superior olivary nuclei and inferior 
colliculus.  
DCN output terminates in the superior olivary nucleus and 
contralateral inferior olivary nucleus through dorsal striae, The 
discharges from these neurons are different from those of AVCN by 
having longer latency. 
The cochlear nuclear complex thus terminates in the superior 
olivary nuclear complex, which has medial and lateral components at the 
base of the pons. The medial superior olivary nucleus receives the input 
from both ipsilateral and contralateral AVCN which are excitory. The 
lateral superior olivary nucleus also receives ipsilateral excitatory inputs 
from AVCN and PVCN and inhibitory inputs from contralateral AVCN 
and PVCN via trapezoid body. From the olivary nuclear complex, the 
impulses travel to ipsilateral and contralateral lemnisci and to inferior 
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colliculi. The olivary nuclei are the first in the auditory pathways where 
the neurons are affected in a non-linear manner to binaural stimulation. 
The inferior colliculi and the lateral lemnisci converge the input 
from contralateral cochlear nucleus and superior olivary nucleus. The 
impulse from inferior colliculus travels to medial geniculate body. 
Neurons in the medial geniculate body form the acoustic radiation of the 
internal capsule, synapsing in the Heschl gyrus of the primary auditory 
cortex (superior temporal gyrus and upper bank of sylvian fissure 
including the frontal and parietal opercula). High frequency tones, such 
as clicks, activate mainly the deeper most mesial portion of the heschl 
gyrus. 
The orderly orientation of the neurons in dorsal cochlear, medial 
and lateral superior olivary nuclei results in summation of synaptic 
potentials which results in high amplitude electrical fields. 
As the auditory impulses travels through the different components 
of the auditory pathway, it undergoes some degree of processing at each 
level. Passage of the impulse through this pathway generates an electrical 
activity which can be monitored by placing a surface (far –field) 
electrode on the vertex of the scalp. On graphic recording, this electrical 
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activity presents a waveform with discrete peaks, the character of which 
is dependent upon the structural and functional integrity of the above 
mentioned auditory pathway. 
           BAEP is produced by presenting auditory stimuli to each ear 
which results in a sequence of waveforms that bear a close relationship to 
the auditory pathway structures (peripheral, pontomedullary, pontine and 
midbrain) and so allows specific localization of pathology in the auditory 
pathway. BAEPs are recorded within 10 milliseconds of the acoustic 
stimulus  
 
 
 
 
 
 
 
Fig. - 5 Normal Auditory Evoked Potential Wave Pattern 
FIGURE : 6 
 
TABLE NO.1 
Generators of BAEP waveforms (Chiappa 1990)36 
Waveform Generators 
I 
II 
III 
IV 
V 
Cochlear nerve 
Cochlear nucleus 
Superior olivary nucleus 
Lateral lemniscus 
Inferior colliculus 
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CLINICAL APPLICATIONS OF BAEP 29,99 
BAEPs have widespread clinical application in assessing both 
neurologic and audiologic problems. It is used in  
1. Detection of deafness in difficult-to-test patients like infants and 
mentally retarded or malingering subjects in whom required 
response will not be available for  subjective pure tone audiometry 
test. This test can be carried out correctly even in deeply sedated 
and anaesthetized patients. 
2. Objectively determining the nature of deafness (i.e., whether 
sensory or neural) in difficult-to-test patients, especially in 
circumstances when the patients cannot follow or respond 
adequately to tests. 
3. Identification of the site of lesion in retro-cochlear pathologies. 
The retro-cochlear pathology is a fairly big area from the spiral 
ganglion of the cochlear nerve to the midbrain (level of inferior 
collicullus). The other tests allow the neurotologists to merely 
suspect whether any retro-cochlear disease is present or not, 
whereas the BERA test helps us to delineate the approximate area 
in the retro-cochlear pathway where the lesion is present. This 
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helps in diagnosing conditions like acoustic neuroma and other CP 
angle tumors with precision and accuracy. 
4. Diagnosis of demyelinating disorders such as multiple sclerosis. 
5. Study of central auditory disorders. Evoked response audiometry 
has been found to be of use in separating disease of the auditory 
cortex from disease of the more peripheral organs. 
6. Study of maturity of the central nervous system in newborns. It is 
an effective screening tool for hearing in the newborn with 
sensitivity of 100% and specificity of 96-98%  
7. For objective identification of brain-death and assessing prognosis 
in comatose patients. 
8. For intraoperative monitoring of eighth nerve and brainstem 
function during posterior fossa surgery(Markand, 1994)93 
Although the AEPs parallel hearing, they do not test hearing per se; 
rather, they reflect a synchronous neural discharge in the auditory system. 
Thus, an individual may have a normal behavioral audiogram and a 
grossly abnormal AEP and central auditory deafness. 
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          Researchers have recently focused on nutritional issues to 
understand mental health problems. Evidences for the role of 
micronutrients  in mental health has come from studies focusing on role 
of zinc in ADHD (Ann M Di Giralamo et al)10. Animal and human 
studies show relationship between low serum zinc concentrations and 
symptoms of ADHD and suggest improvement of symptoms with zinc 
supplementation.  
            Zinc is a trace mineral that is involved in RNA and DNA 
synthesis and it is very important for cellular growth, differentiation and 
metabolism (Sanstead  HH  et  al)129. It is also essential for brain 
development and central nervous system function. More than 200 
enzymes are zinc metalloenzymes requiring zinc for normal development 
of neurons. Zinc deficiency can interfere with function of multiple organ 
systems  particularly  when  it  occurs  at  times  of  rapid  growth  and  
development during which period there is high nutritional demand. 
             The normal zinc intake is about 10-15 mg/day and is excreted 
mainly in the faeces through the intestine. The total zinc content of the 
body is about 2 – 2.5 gms with no tissue stores. The highest zinc content 
is present in the muscles, the bones, liver, male reproductive organs, eyes 
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and hair. The normal serum zinc level is 80 - 170μg/dl with an average of 
124 ± 16μg/dl. Zinc from meat sources have higher bioavailability than 
vegetarian sources due to presence of aminoacids which enhance zinc 
absorption. ADHD children in general have specific liking to vegetarian 
foods rather than non-vegetarian foods and this may be another reason for 
their zinc deficiency.   
            Zinc contributes to behavioral changes such as focusing attention 
and reducing aggressiveness through regulatory effects on certain brain 
neurotransmitters such as melatonin and fatty acids. The prevalence of  
zinc deficiency in ADHD children is about 26% as opposed to 3.3% 
prevalence in the normal children  (Joy Y Kiddie)69. Several studies have 
shown that children with ADHD are more likely to have zinc deficiency 
than other children. One of the studies have shown that taking zinc 
supplements can reduce the symptoms of ADHD. 
          Zinc status is traditionally assessed (Sandstead & Alcock 1997)128 
using plasma& serum assays. This can detect severe as well as marginal 
zinc deficiency, but it has two limitations. Plasma zinc is not always 
sensitive to small changes in chronic zinc status (Thompson, 1991)158 
and serum zinc values are affected by inflammation and physiological 
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stress.  So researchers use dietary restrictions to assess consequences of 
zinc deficiency in animals. Several studies using rats, mice and monkeys 
have examined relation between zinc concentration and behaviors such as 
aggression and attention. Studies in prepubertal monkeys with moderate 
dietary restriction of zinc shows reduced spontaneous motor activity and 
reduced performance of tasks (Golub et al)53. Studies have shown more 
aggressiveness in zinc deficient rats compared to control rats. In humans 
the role of zinc in ADHD is assessed by supplementation of zinc in 
specific doses and observation of improvement of ADHD symptoms in 
suspected zinc deficient ADHD population. 
BIOLOGICAL EFFECTS OF ZINC 
1. Zinc is essential for wound healing. In the form of zinc oxide it is 
used in the treatment of diaper rash (Patel GK., Harding KG)110 
2. Hypothesized to play a role in treatment of inflammatory acne and 
is present in many nutritional supplements for acne (Dreno 
B.,Moyse D et al)44 
3. Zinc sulphate combined with vit c is being used in treatment of bed 
sores. 
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4. Zinc is known to boost up immunity and it is used in chronic 
herpes infection (Chien XX et al)37 
5. Zinc lozenges are under trial for common cold. 
6. Zinc preparations are used to hasten up recovery from diarrhea. 
7. Plays a role in limiting inflammation 
8. It’s role is being explored in Alzheimer’s disease. 
9. It plays an important role in fertility of males and also required by 
females for ovulation. 
10. Studies have shown that Diabetic neuropathy improves with zinc 
supplementation as evidenced by improvement in nerve conduction 
studies (Hayee MA., Mohammerd QD., Haque A)58 
11.  Zinc has been shown to be effective in the treatment of Age 
related macular degeneration. 
12.  Zinc increases the response to treatment with conventional 
stimulant treatment in ADHD children Sources rich in zinc include 
oysters, sea food, beef, chicken, pork, nuts and whole grains. 
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ROLE OF ZINC IN THE PATHOGENESIS OF ADHD 
             Several mechanisms have been suggested to explain the role of 
zinc in the pathogenesis of  ADHD. Most of the mechanisms possibly 
acts through alterations in neurotransmitters such as dopamine and 
serotonin involved in the pathogenesis of ADHD. 
            Zinc is a cofactor for metabolism of several neurotransmitters 
such as dopamine and prostaglandins and thus affects dopamine which is 
involved in the pathogenesis of ADHD indirectly (Toren et al, 1996)161 
            Zinc is essential for the production and modulation of melatonin 
which regulates dopamine function (Chien  XX  et  al)37. There is a 
proposal that parasympathomimetic stimulants act in ADHD partly 
through its effect on melatonin. Dopamine transporter (DAT 1) which is 
involved in the degradation of dopamine  has an endogenous zinc binding 
site on binding to which zinc acts as a non-competitive blocker and 
prevents dopamine binding to the transporter  and thus increases the 
availability of extracellular dopamine by decreasing its degradation   
(Lepping P. Haber M)82.  
            Zinc is essential for the conversion of dietary pyridoxine to its 
active form, pyridoxal phosphate which is necessary for conversion of 
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tryptophan to serotonin (Bilici M et al)28.  As  both  dopamine  and  
serotonin neurotransmitters are implicated in ADHD (Quist JR) 
supplementation of zinc deficient ADHD children with zinc may improve 
the levels of deficient neurotransmitters  and thus improve ADHD 
symptoms of impulsivity (Bilici M et al)28 (Arnold LE,  
Di silvestro RA)11. 
            Zinc may also influence the N2 wave in the frontal and parietal 
regions  of  the  brain  with  effects  seen  on  information  processing  and  on  
inhibitory processes in the CNS which is affected in ADHD children. 
Evidences show increase zinc ion release during neuronal activity  
(Li et al., 2003)87 
           Zinc is essential for maintaining the neuronal structure by 
affecting the metabolism of polyunsaturated fatty acids (PUFA) which 
are the building blocks of neuronal membranes (Black 1998)23. It acts as 
a cofactor for the enzyme delta-6-desaturase which is involved in the 
anabolism of PUFA that constitute the neuronal membrane (Bettger et 
al, 1979)22 
           Zinc interacts with Essential Fatty Acid metabolism in a number 
of ways (Bekaroglu et al, 1996)20.  EFA  is  a  substrate  for  the  enzyme  
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delta-6-desaturase which modulates cyclooxygenase activity (Sakuma127   
et al, 1996). Cyclooxygenase is required for production of prostaglandins 
and thromboxanes from EFA precursors which inturn facilitate zinc 
absorption (Song & Adham ,1980)139. EFAs are involved in dopamine 
and norepinephrine implicated in the pathogenesis of ADHD        
(Molderings et al,1992)101. A significant correlation is seen between 
serum zinc and FFA levels in patients with ADHD who had lower levels 
of  both  serum  zinc  and  FFAs  than  the  healthy  controls  (Bekaroglu  
et al)20. Thus EFAs and zinc play a synergistic role in the regulation of  
dopamine, norepinephrine and probably serotonin and so zinc and fatty 
acids supplementation may be beneficial in improving symptoms in the 
deficiency group. 
Kozielec et al(1994)76 in Poland showed that serum zinc levels 
were significantly lower in ADHD children compared to healthy controls. 
Toren et al(1996)161 in Israel reported significantly lower serum 
zinc levels in a group of 39 boys and 4 girls with ADHD in the age group 
of 6-16 yrs compared to 28 age matched controls. About 30% of ADHD 
children had serum zinc levels in the lower range compared to controls. It 
was suggested that the ADHD symptoms of hyperactivity was due to zinc 
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deficiency and did not respond to amphetamine but improved with zinc 
supplementation. 
Bekaroglu et al(1996)20 in Turkey recorded  low mean serum zinc 
levels in 48 children( 33 boys and 15 girls) with ADHD compared to 
healthy controls(30 boys and 15 girls). He evaluated the relationship 
between FFAs, zn and ADHD in the two groups and found statistically 
significant decrease in FFAs and zinc levels in ADHD children. He 
concluded that zinc deficiency may have a role in the pathogenesis of 
ADHD. 
Starobrat-Hermelin et al(1998)142 in Poland reported deficiencies 
of zinc, magnesium, iron, copper and calcium in 116  ADHD children by 
analysis of serum, red blood cells and hair. Hair zinc levels were lower in 
ADHD with comorbid conditions like ODD or conduct disorder than in 
children with ADHD alone. 
Arnold et al (2005)12 in an American study reported that severity 
of ADHD symptoms were related to serum zinc concentration. He 
showed that serum zinc correlated with parent and teacher rated 
inattention but not with Hyperactivity and impulsivity in US children 
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with ADHD where as a similar study in Turkey showed serum zinc 
correlation with hyperactivity rather than inattention. 
Sandstead et al(1997)128 reported that Chinese children with 
marginal zinc deficiency as evidenced by serum levels showed 
improvement in neuropsychological performance on zinc 
supplementation. 
Orner et al, (2010)109 showed that low serum zinc and ferritin 
levels were associated with higher hyperactivity symptoms in children 
with ADHD. 
Magdy M. Mahmoud et al89 in Egypt showed that serum zinc, 
ferritin and magnesium levels were significantly lower in children with 
ADHD than normal controls but there was no significant difference in 
copper levels. 
Arnold et al (1990)14 showed that 18ADHD children had 30% 
lower 24 hours urine zinc than 7 normal controls. He projected that this 
could be due to low dietary intake or absorption rather than zinc wasting 
metabolism. 
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Akhonzadeh et al(2004)4 showed that zinc supplementation of 
ADHD children along with conventional stimulant drugs like 
methylphenidate (MPH) increases the response to drugs. Study in 44 
Iranian children with ADHD of age 5-11 yrs showed significant 
improvement in ADHD children who were supplemented with zinc along 
with MPH rather than with MPH and placebo. 
Arnold et al13 found that response of a group of  6-12 yrs boys 
with ADHD to the drug amphetamine was related to zinc concentration. 
Stronger  response was seen in children with adequate zinc concentration. 
In another placebo controlled pilot study of zinc alone and combined with 
amphetamine , he showed that clinical effect of zinc was equivocal 
except that there was a 37% decrease in dose of amphetamine.  
Bilici et al28 in Turkey showed that zinc sulphate was statistically 
superior to placebo in reducing both hyperactive and impulsive 
symptoms and impaired socialization but not inattentive symptoms. He 
found that the scores decreased significantly inpatients of older age and 
high BMI score with low serum zinc and FFA levels. 
J. Gordon Millichap et al 64 found that low zinc levels are seen in 
serum, red cells, hair, urine and nails of ADHD children.  
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Mikirova et al97 suggested that correction of serum zinc levels in 
ADHD children improved the behavioural responses. 
Ward et al(1990)166,167 suggested a possibility of exacerbation of 
marginal zinc deficiency by food additives and other chemical 
interactions. He challenged 10 hyperactive boys and 10 controls with 
tartrazine containing commercial beverages and found that serum and 
saliva zinc decreased while urine zinc increased in hyperactive and not 
the  control  boys  which  suggests  zinc  wasting  from the  body  due  to  dye  
challenge. 
Halas et al55 examined zinc deficiency in rats during infancy 
period by depleting zinc levels during the period of development and then 
replenishing them with zinc rich foods and then examined their behavior 
in adulthood. Early severe zinc deficiency leads to increased emotionality 
in adulthood. 
Sandstead et al (1977)129 studied the effect of zinc deficiency on 
behavior of rats and rhesus monkeys and showed association of ADHD 
symptoms with zinc deficiency. 
Golub et al53 reported impairment of attention at levels that did not 
cause growth retardation. He also showed that short term zinc deprivation 
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in prepubertal monkeys resulted in reduced motor activity and less 
accurate performance on measures of attention and short term memory. 
Arnold et al(2005)11 reviewed published evidences for the role of 
zinc in ADHD and reported its limitations and concluded that many 
children with ADHD have lower serum zinc levels than normal controls, 
zinc nutritional status may interact with food additives and two mid-
eastern trials showed greater improvement with zinc supplements than 
with placebo. 
Animal and clinical trials implicate deficiencies of zinc as an 
essential cofactor in neurotransmitter, prostaglandin, and melatonin 
metabolism and thus in ADHD pathophysiology.  
          The literature and studies reviewed here show that reduced serum 
zinc levels could be markers for EFA deficiency which is the substrate 
for prostaglandins required for zinc absorption (Song and Adham)139 or  
they could be markers for general malnutrition (Wesnes et al)168. Zinc 
levels could be markers of a gene that results in decreased absorption of 
zinc or it could be marker of inflammation during which zinc levels are 
decreased suggesting immune problems (Shenkin 1995)135. Decreased 
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zinc levels could be due to exacerbation of marginal zinc deficiency by 
food additives, drugs or other chemicals.  
Thus from the above facts we can infer that 
1. Many ADHD children have lower zinc levels compared to healthy 
controls.  
2. Ingested chemicals such as food additives may interact with zinc 
nutritional status and may cause zinc deficiency 
3.  Zinc supplements improve symptoms of ADHD in zinc deficient 
children. Several clinical trials are expected in the future to 
elucidate the role of zinc in ADHD as a monotherapy, as an 
adjunct to stimulant treatment and also to evaluate the relationship 
of  other  nutrients  to  zinc  and  the  effect  of  food  additives  on  zinc  
levels which will be beneficial to the community. Thus in the 
present study work is undertaken to study the levels of serum zinc 
in ADHD children and find out if zinc has been involved in the 
pathogenesis of ADHD, with the aim of reducing the incidence of 
ADHD that may occur as a result of zinc deficiency. 
Serum zinc levels can be measured by Atomic Absorption 
Spectrophotometry or colorimetric methods. 
 Aim and Objectives 
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3.  AIM AND OBJECTIVES 
AIM      
To assess the central auditory processing using Brainstem auditory 
evoked potential and to measure serum zinc levels in children  with  
Attention Deficit Hyperactivity Disorder in comparison with age and sex 
matched controls. 
OBJECTIVES  
1. To assess the brainstem auditory evoked potential in children with 
Attention Deficit Hyperactivity Disorder (ADHD). 
2. To determine the role of brainstem auditory evoked potential in the 
pathophysiology of  ADHD 
3.  To  compare  the  serum  zinc  levels  of  children  with  ADHD  and  
normal children. 
4. To correlate serum  zinc levels with brainstem auditory evoked 
potential 
  
 Materials & Methods 
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4.  MATERIALS AND METHODS 
The study was conducted between March 2014 to August 2014 in 
the INSTITUTE OF PHYSIOLOGY AND EXPERIMENTAL 
MEDICINE, MADRAS MEDICAL COLLEGE after receiving the 
approval from the Institutional Ethical Committee, Madras Medical 
College, Chennai. 
SUBJECT SELECTION 
          Thirty male children between 6-11 yrs diagnosed with ADHD, 
according to DSM IV criteria and getting treatment were selected from 
the Child Guidance Clinic, Institute of Child Health, Egmore, Chennai-
600 008  to participate in the study and thirty age matched apparently 
healthy male children selected from community were the controls. 
Informed consent was obtained from the parents of ADHD children and 
also controls. 
PATIENT SELECTION 
Diagnosis of ADHD was made using DSM IV criteria according to 
which ADHD is divided into three subtypes namely predominantly 
inattentive type, hyperactive-impulsive type and combined type. Ten 
male children from each of the three subtypes accounting to a total of 30 
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were selected for the present study from the children  attending the Child 
Guidance Clinic in the Institute of Child Health. Assessment was done 
using Parent Rating Scale and Vanderbilt ADHD Diagnostic Teacher 
Rating Scale. IQ Assessment was done using the Malin’s Intelligence 
scale  for  Indian  Children  (MISIC).  Only  children  with  IQ  equal  to  or  
greater than 90 were selected for the study.  
INCLUSION CRITERIA 
Children in the age group of 6-11 yrs diagnosed with ADHD. 
EXCLUSION CRITERIA 
Children with 
Autism, Pervasive developmental Disorder, perinatal hypoxia, 
Developmental delay, Epilepsy, CNS infection, Demyelinating disorders,  
Hearing disability, chronic medical illness,  Malabsorption, General 
malnutrition, other psychiatric disorders. 
STUDY DESIGN  :  Cross sectional study 
 
TYPE OF STUDY    :  Comparative study 
 
PLACE OF STUDY :  Institute of Physiology and  
    Experimental Medicine,  
                                             Madras Medical College, Chennai – 3. 
                                               Institute of Child Health, Egmore,  
Chennai – 8.  
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HISTORY 
Detailed history was collected from the parents of both controls 
and ADHD children. This includes information regarding birth 
complications such as preterm delivery, perinatal hypoxia and family 
history of ADHD and other psychiatric and neurological disorders. 
Enquiry should also be made about the socioeconomic status as ADHD is 
found to be common in low socio-economic status. In addition dietary 
history and history of allergy to foods containing additives should also be 
collected. 
CLINICAL EXAMINATION 
Common For Both Study and Control Groups 
Regular anthropometric measurements (height and weight) were 
taken in both groups. BMI was calculated using the formula weight in 
kg/height in cm2 and BMI percentile was compared between normal 
healthy children of same age and sex (Must et al104) 
BMI between 5th and 85th percentile is normal. 
BMI  between 85th and 95th percentile is overweight. 
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BMI less than 5th percentile is underweight. 
BMI greater than 95th percentile is obese (Himes & Dietz 199460) 
Vitals (Pulse, BP, Respiratory rate and temperature) were measured. 
General examination of the subjects of both groups were done. 
Systemic examinations including cardiovascular system, Respiratory 
system and Central Nervous system including Cranial Nerve 
examinations were done. 
For the study group, these basic clinical examinations were done in 
Institute of Child Health. For the control group, these clinical 
examinations were done in the Institute of Physiology and Experimental 
Medicine. 
SPECIFIC ENT EXAMINATION 
Both the groups of the subjects were subjected for specific ENT 
examinations in the Upgraded Institute of Otorhinolaryngology, Madras 
Medical College, Chennai. 
The ENT examination includes external ear examination, turning 
fork tests which include Rinne’s Test and Weber’s Test, otoscopic 
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examination of tympanic membrane, presence of any obstruction by wax 
and examination of throat and nose. 
If  there  is  any  presence  of  obstruction  by  wax,  it  was  promptly  
dissolved by appropriate treatment before subjecting them for Pure tone 
Audiometry. 
PURE TONE AUDIOMETRY 
Both the group of subjects were subjected for Pure Audiometry in 
the Upgraded Institute of Otorhinolaryngology. 
This is done to 
i. Know the hearing threshold of the subjects. 
ii. To rule out any external or middle ear pathology {integrity of 
conductive pathway} 
PRINCIPLE AND METHOD OF PURE TONE AUDIOMETRY88 
This is the most commonly used method of measuring hearing 
acuity. A pure-tone audiometer is an instrument which delivers tones of 
variable frequencies and intensity to the ear by ear phone. The 
frequencies usually tested are at octave steps, i.e. 125, 250, 500, 1000, 
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2000, 4000 and 8000 Hz. Occasionally half octave steps, such as 1500, 
3000 and 6000 Hz area used. The intensity can be increased or decreased 
for each frequency and can vary from 10 dB to 120 dB. Most audiometers 
used today are calibrated to the International Standard Level (ISO). 
Both the air conduction and bone conduction can be measured and 
are done in the same manner. The best frequency to start with is 1000 Hz. 
A  series  of  short  signals  or  tone-pips  are  put  in  at  intensity  above  the  
patient’s suspected threshold and the patient is instructed to signal every 
time he hears a sound. The intensity is reduced in 10 dB steps until no 
sound is heard. The signal is then increased in 5 dB steps until half of the 
tone pips are consistently heard. This is the patient’s threshold for that 
frequency. The thresholds for the remaining frequencies are then 
measured. The bone conduction is measured in a similar fashion by 
putting a receiver onto the mastoid bone. The sound emitted by this is 
transmitted  by  the  bones  of  the  skull  to  the  cochlea,  thus  bypassing  the  
external and middle ears and giving a measure of inner ear function. The 
results are charted as audiograms. 
In audiometry, it is important to eliminate the possibility that the 
test sound is being heard in the opposite ear. Masking must be applied to 
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the better ear when testing the deafer ear if the difference in threshold is 
found to be 40 dB or more. When testing the bone conduction threshold, 
the other ear should always be masked because of the ease with which 
bone conduction sound is transmitted through the bones of the skull. 
BRAIN STEM AUDITORY EVOKED POTENTIAL 
Both the groups (ADHD children and normal children) were 
subjected to non-invasive assessment of hearing and central auditory 
processing of stimuli i.e., by Brain Stem Evoked Response Audiometry 
(BERA) /Brainstem Auditory Evoked Potential (BAEP) /Auditory 
Brainstem response(ABR).   
PRINCIPLE OF BAEP 
A brief auditory stimulus generates action potentials in the auditory 
pathway which are recorded from the ear and vertex as BAEPs. The 
evoked response audiometry is based on the principle that the bioelectric 
response evoked by a sound stimulus always occurs after  the same time 
interval (Lau S. K. & William I. Wei)81 
 
 
PHOTO NO.1 
COMPUTERISED NEUROSTIM MEDICAID SYSTEM FOR  
RECORDING BAEP 
 
  
74 
 
 
APPARATUS FOR BAEP 
 The apparatus set up for measuring BAEP are set as per the 
“Recommended standards for the clinical apparatus for practice of 
Evoked Potentials, introduced in guideline 9A7: Guidelines on evoked 
potential, by American Society of Clinical Neurophysiology. 
The apparatus for BAEP used in our study is NEUROSTIM of 
Medicaid Systems 
 
 
 
 
 
 
 
 
 
 
FIGURE : 7 
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PULSE GENERATOR 
       The stimulus is either in the form of clicks or tone-pips and is 
transmitted to the ear via a transducer placed in the insert ear phone or 
head phone. The click stimulus is a square wave pulse of 0.1 ms duration. 
The stimulation of contralateral ear is prevented by masking it with a 
white noise of about 30-40 dB. 
RECORDING ELECTRODES 
         The electrodes required for BERA measurement are placed in the 
corresponding sites of the scalp following the International 10-20 
Electrode placement system. High quality EEG electrodes are used. Both 
needle and surface electrodes are used for recording BAEPs. Surface 
electrodes are preferred because it is painless and there are lower chances 
of infection.  
             For better placement of electrodes, the hair must be oil free. The 
patient should be instructed to have shampoo bath before coming for 
investigation. 1cm disc electrodes filled with conducting jelly or paste is 
preferred. The electrical impedance should be kept below 5 kilo ohms. If 
the impedance is too high, the skin is cleaned again with acetone and the 
surface electrode is reapplied together with electrode jelly or EEG paste.  
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Active and ground electrodes are placed on the ipsilateral and 
contralateral mastoid processes respectively, after the skin has been 
cleaned. The electrode on the vertex acts as the reference. 
FILTER 
          Filter is a device, which selectively restricts the frequency domain 
of a signal. The filter band pass is the frequency range of a signal, which 
is transmitted through the filter. The frequency range in which the signal 
is rejected is known as stop band. Filtering of neurophysiological signals 
is required for eliminating the noise and optimising the recording. 
Filtering is also useful for bringing out the characteristics of the 
waveforms. 
         The low frequency filter removes the slowly changing low 
frequency components and allows the higher frequencies to pass through. 
Therefore, the low frequency filter is also known as high pass filters. 
Similarly, the high frequency filter eliminates the rapidly changing high 
frequency components and allows the low frequency component to pass 
through. Hence the high frequency filters are known as low pass filters.  
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         Filter setting for BERA is as follows; 
 Low – cut filter: 10 – 100 Hz. 
 High – cut filter: 3000 Hz. 
AMPLIFIER 
            Since  the  biological  signals  are  very  small  (5  to  50mv), variable 
degree of amplification (200,000 - 500,000 times) is needed equal to the 
range of analog to digital convertor. The electrode impedance includes 
intrinsic impedance of the electrodes and the impedance of electrode-skin 
interface. For the measurement of any electrical activity say for example, 
the action potential generated in central nervous system, nerve or muscle 
must flow through the electrode into the amplifier and return to the 
patient through the ground lead. Electrode impedance results in drop of 
the amplitude of action potential. 
            This attenuated action potential reaches the amplifier. To reduce 
this attenuation, the impedance of the amplifier must be much greater 
than the electrode impedance. According to the recommended standards 
of the Guideline 9(A) the differential input impedance of the amplifier 
must be at least 100 mega ohms. This minimises the waveform distortion 
and improves noise rejection. Unequal electrode impedance imbalances 
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the electrode amplifier input, converting some of the noise into a 
differential signal, which is amplified to the same extent as the 
neurophysiological signal. 
SIGNAL AVERAGER 
          The process of measuring the electrical activity in the brain in 
response to sound stimulus presented to the ear, is a very complicated and 
cumbersome process. This is so, because, some degree of random of 
random and spontaneous electrical activity is continuously occurring 
within the brain. A recording of this random electrical activity is called 
ELECTROENCEPHALOGRAPHY (EEG). The electrical activity set up 
in the brain, in response to a sound stimulus, mingles up and mixes with 
the random and spontaneous electrical activity occurring within the brain 
and gets obscured. The magnitude of the electrical activity evoked by a 
sound stimulus is only about 1/100 of that of spontaneous random 
electrical activity (which is also called ‘Background potential’). To 
separate these two types of electrical activity, a process called ‘signal 
averaging’ is done. This is based on the fact that, evoked electrical 
activity is time specific and occur at a fixed point of  time after the sound 
stimulation, whereas, the random electrical activity is not time specific 
and occur at random. Hence, if the electrical activity generated by a very 
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large number of separate sound stimuli at a specific point of time is added 
together, only the electrical activity evoked by the sound stimulus will 
keep on adding, whereas, the background potential occurring at random 
without any time specificity will cancel each other. Thus this signal 
averaging technique is used to clarify and not amplify the response and 
enables to get the uncontaminated measure of the sound evoked electrical 
activity. 
 A 10 millisecond epoch after the stimulus is generally averaged for 
BAEP studies. Atleast 1000 – 2000 trails are averaged to get a good quality 
recording. Two to three repetitions are done and done and superimposed to 
check for reproducibility. The latency values measured on the separate 
repetitions should agree with each other within 0.1 millisecond or less. The 
amplitude values should agree with each other within 10%. 
DISPLAY 
       There are two techniques of display of waveforms namely 
1. Analog Oscilloscope Display 
2. Computer based digital video display 
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       In Analog oscilloscope display neurophysiological signals are directly 
displayed on a cathode ray tube following amplification and filtering, 
advantage of which is that there is no limitation for dynamic high frequency 
response and it’s an optimal means of displaying rapidly changing amplitude 
against time. 
For digital display, Analog to Digital Converter (ADC) and digital 
processing technique are required and this is used in our apparatus 
NEUROSTIM.  The  analog  to  digital  conversion  is  a  process  in  which  the  
continuously varying neurophysiological signal is sampled at discrete time 
intervals and the amplitude of signal is converted to a number following 
amplification and filtering. The unit of an ADC is a bit, which is a binary 
digit(0 or 1). 
SENSITIVITY(GAIN) & SWEEP TIME 
        The latency and duration measurements of an action potential are 
influenced by the sensitivity and sweep time . On high sensitivity, the latency 
measurements are shorter. Increase in sweep speed results in shortening of 
latency.                  
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ELECTRICAL SAFETY 
         In recording BERA, measures must be taken to assure the patient’s 
safety. The grounding and the chassis leakage of all instruments 
connected to the patient or located in the same room as the patient must 
be must be periodically tested. Equipment should be designed to prevent 
inadvertent shock during power on, power – off and failures. 
BAEP settings in our study  
Apparatus    : NEUROSTIM of Medicaid Systems 
Electrical Montage : L: Cz – A1, R: Cz – A2  Ground: Fz 
Amplifier   : Low filter – 100 Hz   High filter -3000 Hz 
Analysis Time   : 10 milliseconds 
Number of EPOCHS  : 2000 trails with two repetitions. 
Nature of the stimulus to the test ear: 
Broad band click of 100 micro seconds duration 
 Intensity – 80 dB 
          Stimulus rate – 11.1 clicks per second 
Masking of Contra lateral ear: 
 By white noise of 50-60 dB is used. 
 PHOTO NO. 2 
BAEP RECORDING IN A NORMAL CHILD 
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RECORDING PROCEDURE 
The BAEPs were recorded from the scalp of each subject  using a 
computerized EP recorder with gold plated disc electrodes placed 
according to the 10-20 international system and adjusting our EP recorder 
to the above specified settings. Active and ground electrodes are placed 
on the ipsilateral and contralateral mastoid processes respectively after 
cleaning the site with alcohol and application of EEG paste. The 
electrode on vertex acts as the reference. The skin-electrode impedance 
was kept below 5 ohms. The BAEP recording of each child was done in 
the presence of a parent. 
 NORMAL BAEP WAVEFORMS99 
Auditory stimuli delivered to one or both ears evoke five to seven 
vertex positive waves in the human scalp, which appears about 10 
milliseconds after the stimulus (Picton et al, 1974)112. These waves are 
named  according  to  the  sequence  using  roman  numerals  (I  to  VII)  
(Chiappa et al, 1975)36. The initial five peaks are of clinical interest.       
  
 
FIGURE 8. GENERATORS OF BAEP WAVES 
 
 
VIII N        :   Vestibulocochlear Nerve 
CN              :    Cochlear nucleus 
SON            :    Superior Olivary Nucleus 
LL               :    Lateral Lemniscus 
IC                :    Inferior Colliculus 
MGB           :    Medial Geniculate Body 
AUD RAD  :    Auditory Radiation 
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WAVE I  
         This is the initial upgoing peak in the ipsilateral recording channel 
just beyond the one millisecond mark on the BERA graph. It is generated 
from the auditory portion of the eighth cranial nerve, that is the proximal 
portion of the nerve lateral to the brainstem in contact with spiral ganglia. 
It is an important reference point for interpeak latency measurement 
(Row MJ, 1978)123. It appears 1.4 ms after the stimulus in normal 
subjects. Medial earlobe recording provides higher amplitude of wave I 
compared to mastoid recording (Stockyard et al, 1979)148.This wave has 
to be recognised properly, because it gives us an idea whether the 
stimulus has crossed over from the cochlea and the distal end of auditory 
nerve, so that various BERA parameters of subsequent waveforms  can 
be studied. If wave I is present, but wave II-V are absent, it suggests that 
the stimulus has reached the cochlea well enough, but is not being able to 
proceed further. If wave I is delayed (ie. Latency increased), but the 
interpeak latencies of I-II or I-V are normal, it  indicates that either there 
is a conductive or cochlear pathology but once the impulse manage to 
cross the cochlea there is no subsequent obstruction, i.e. no retro-cochlear 
pathology. So, patients who have a CNS problem should have a 
preserved wave I, whereas those with peripheral hearing impairment may 
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have absent or poorly formed wave I, but relatively normal waves II – V 
(Nuwer et al, 1994)107.  The  wave  I  is  a  consistent  BERA  wave  and  is  
present in all normal subjects. Only marked peripheral lesions (cochlear 
or conductive pathology) abolish the waves. 
WAVE II  
 It may be generated either at the cochlear nucleus or near the 
cochlear nucleus (Row 111, 1978)123. A portion of it may come from the 
auditory nerve fibres around the cochlear nucleus and this part of wave II 
may be preserved even in brainstem dead patients. Wave II may be 
poorly defined in neonates and some adults. It may sometimes appear as 
a small peak along the downgoing slope of wave I or may merge into the 
upgoing slope of wave III. This wave has a latency of approximately 2.8 
millisec. And hence when it difficult to identify it should be looked for at 
or just before the 3ms mark of the BERA. It is more prominent and also 
has a prolonged latency  on the contralateral recording channel compared 
to ipsilateral channel, sometimes fusing with wave III forming an  
M – shaped II-III complex (Aminoff et al, 1994)8 
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WAVE III 
 This  wave  probably  originates  from  the  lower  pons  as  the   
impulse travels through the superior olivary nucleus and trapezoid body 
(Row III, 1978)123.This wave precedes the wave IV. So, once the wave 
IV has been recognised wave III is identified as the upward peak between 
wave II and IV just beyond the 3ms mark on the graph. Wave III is 
usually a prominent peak and is followed by a prominent trough. In the 
contralateral channel wave III is smaller and appears earlier than in the 
ipsilateral channel because its amplitude is similar at the vertex and 
contralateral ear (Goodin et al, 1994)54. Sometimes the wave III  is  bifid 
and rarely it is fused with wave II. These are normal variants and has no 
clinical significance. In normal subjects the wave III is usually present at 
or around the 3.8ms mark on the BERA graph. The amplitude is of about 
.20 to .25 microvolts. The wave III is as consistent as I and V and in only 
about 1-2 % cases, the wave III may be absent in normal subjects. 
WAVE IV 
         This wave is identified as the peak just preceding the wave V. So 
once wave V is identified, it not difficult to identify wave IV. Sometimes 
however wave IV and wave V become superimposed leading to 
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difficulties in identification of the waves. In such cases, it is worthwhile 
in using the contra- lateral ear as the reference. Other variations of wave 
IV are superimposition of wave V in the down slope i.e. descending arm 
of  wave  IV  as  also  the  superimposition  of  the  small  wave  IV  in  the  
upstroke i.e. the ascending arm of wave V. These are normal variation 
and do not have clinical significance. 
 A distinct and separately identified wave IV is present in only  
50-60% of subjects, in other cases the wave IV cannot be identified 
separately. 
WAVE  V  
 This wave ought to be identified before all of the other waves. It is 
the  most reliable and easily identified wave in the BERA. The hallmark 
of the wave V is that there is a sharp negative (downward) deflection 
immediately following the peak. Hence ,when we find a peak beyond the 
5ms mark on the graph which is followed by a long and sharp downward 
deflection dipping below the arbitrary horizontal line which bisects the 
other wave, one can identify it as wave V. Sometimes, however it is 
difficult to distinguish wave V from wave VI as the long sharp negative 
deflection atypically follows the peak of wave VI (instead of that of  
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wave V). However, in such confusion the clinician should ask for Cz-Ac 
recording of the BERA.Cz – Ac mean that the active recording electrode 
is on the vertex and the reference electrode is on the contra-lateral ear 
lobe .The wave V usually appears at 5.6 – 5.85 ms in normal subjects 
when the BERA test is done at 50 – 60 dB supra threshold level. Though 
the amplitude of the BERA waves is variable , yet it is usually the target 
and the most robust of the five BERA waves. It is always bigger than 
wave I and is usually nearly twice the size of wave I. Generators of wave 
IV&V probably lie in the upper pons or lower midbrain, lateral lemniscus 
and inferior colliculus. There are conflicting reports about ipsilateral or 
contralateral generation of waves IV & V but most of the evidences show 
a contralateral site of generation for wave V (Starr et al, 1994)144. 
WAVES VI & VII 
         They are not found in all normal subjects. They are generated in 
medial geniculate body and auditory radiation from the thalamus to 
temporal cortex respectively (Row, 1980)122 
INTERPRETATION OF BAEP WAVEFORMS 
        The  most  constant  and  important  waves  are  waves  I,  III  &  V  
(Rosenhall et al.,1985)121 
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 The parameter of the Brainstem auditory evoked potentials that are 
studied are as follows. 
a. Absolute latency and amplitude 
b. Inter peak latencies ( IPL ) 
c. Amplitude ratio of wave V / I complex 
d. Inter ear inter peak differences. 
       The  amplitude  of  the  BAEP  waveforms  depends  on  the  number  of  
neurons  activated  by  the  auditory  click  stimulus  and  the  level  of  
synchronized activity of these neurons. The interpeaklatencies (IPLs) 
reflects conduction of the nerve impulse(AP) through the corresponding  
component of the auditory pathway (Stockard JJ) 147. 
Absolute latency  
 Latency of a wave is the time interval between the onset of the 
stimulus and the peak of the wave measured in milliseconds. Absolute 
latencies are taken from the peak of the respective wave. The 
recommended method for latency comparison is to superimpose the 
major  ascending  and  descending  limbs  of  waves  of  two  sides  against  a  
strong source of light. The absolute latency of the wave is most important 
for clinical measurement because it is most commonly present and easily 
identifiable. 
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Absolute amplitude 
 Amplitudes area not a very good criterion since amplitude of the 
wave  is  not  as  constant  as  latency  of  the  waves.  However  amplitude  
measurements do yield some information which is used as supplementary 
evidence. Absolute amplitude are measured in microvolts from the peak 
of the wave to its trough. The absolute amplitudes are extremely variable 
in normal subjects (Chiappa K.H)36. 
INTER PEAK  LATENCY (IPL) 
 Inter peak latency or inter wave latency is time interval between 
two different waves in the same ear. The clinical interpretation is based 
on IPLs (Chiappa K.H)36. The commonest IPLs used in clinical practice 
are : 
I- V IPL 
 The latency difference between wave V and wave I is the measure 
of conduction from proximal VIII nerve through pons to mid brain. It is 
prolonged in various disorders such as demyelination, ischaemia and 
tumors which produce focal damage and degenerative disorders and 
hypoxia which produces diffuse damage (Starr et al.,1994)144. The upper 
limit  of  normal  for  I-V  IPL  is  4.5  msec.  This  IPL  is  slightly  shorter  in  
females and in older men. Normal right to left asymmetry should not 
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exceed 0.5ms. For full term infants this interval should be less than 
5.4msec (Goodin et al.,1994)54. 
I- III IPL 
 The latency difference between wave III and I is a measure of 
conduction from VIII nerve across subarachnoid space into the core of 
the lower pons. This I-III IPL will be prolonged in lesions affecting the 
pontomedullary junction where the eighth nerve enters the brainstem or 
in the lower pons around superior olive or trapezoid body. Acoustic 
neuromas  or  other  CP  angle  tumors  can  cause  a  delay  at  this  juncture.  
Inflammation in subarachnoid space such as subarachnoid haemorrhage 
also can increase this interval (Aminoff et al., 1994)8. The upper limit of 
normal I-III IPL is about2.5 msec. Normal right-left asymmetry should 
not exceed 0.5 msec. An excessively long I-III IPL should not be 
considered unless there is associated prolongation of I-V IPL (Matsuoka 
et al.,1994)94   
III – V IPL  
 III  – V IPL is  the measure of  conduction from lower pons to mid 
brain. It is probably influenced by contra lateral conduction although 
contribution from ipsi lateral brain stem auditory pathways is also 
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suggested. Most of the evidences suggest contralateral brainstem site 
(Nuwer et al.,1994)107.  The upper limit of normal III-V IPL is about 2.4 
msec. Normal right-left asymmetry should not exceed 0.5 msec. An 
excessively long III-V IPL is not considered abnormal unless I-V interval 
or V/I amplitude ratio is also abnormal (Goodin et al., 1994)54 
Amplitude ratio of wave V/I 
 The measurement commonly used in amplitude studies is 
amplitude related ratio, which is the ratio between the amplitude of two 
waves. Commonly the amplitude ratio of wave V/I is used clinically. 
Since the wave I is generated outside the CNS and wave V inside, these 
can be compared to determine the relationship of expected signal 
amplitude. It can be expressed either as percentage or ratio. The 
amplitude ratio should be between 50% and 300%. When the V/I 
amplitude ratio is  less than 50% it  suggests  a  small  wave V and central  
hearing impairment. When the V/I amplitude ratio is greater than 300%, 
wave I is considered small and suggests peripheral hearing impairment 
such as high frequency or sensorineural hearing loss (Aminoff et 
al.,1994)8.For full-term infants the lower limit of V/I is 30% (Goodin et 
al.,1994)54. 
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Inter ear latency difference 
 It is the time interval difference between the two ears of the same 
wave. The difference in the absolute latency of a particular wave in 
between the two ears should not be more 0.5 ms, provided the same supra 
threshold sound stimulus has been presented to the two ears. 
      Table 2. NORMALWAVES OF BAEP 
Waves(latency ms) Chiappa et al1979 Misra and Kalita et al 
I 
II 
III 
IV 
V 
VI 
I – III IPL 
I – V IPL 
III – V IPL 
1.7  ± 0.15 
2.8 ± 0.17 
3.9 ± 0.19 
5.1 ± 0.24 
5.7 ± 0.25 
7.3 ± 0.29 
2.1 ± 0.15 
4.0 ± 0.23 
1.9 ± 0.18 
1.67 ± 0.17 
2.78 ± 0.21 
3.65 ± 0.22 
5.0 ± 0.30 
5.72 ± 0.30 
7.2 ± 0.48 
1.99 ± 0.25 
4.04 ± 0.25 
2.08 ± 0.30 
 
Terminologies used in evoked potential study(click stimulus intensity) 
decibel (dB=1/10 Bel): 
It is defined as ‘20 log (P1/P2)’, where P1 is the intensity of the sound to 
be measured and P2 is the intensity of the reference sound. 
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Sound pressure level (SPL): 
It is the weakest sound heard by the most sensitive ear. It is the standard 
physical reference for sound (20 micropascals or 0.0002 dynes /cm2) 
Hearing level (dBHL): 
Zero dBHL corresponds to the average hearing threshold of a group of 
normal hearing young adults in a ideal listening environment. 
Sensory level (dBSL): 
This expresses the intensity of a sound as a function of the hearing 
threshold for an individual ear for any subject. 
FACTORS AFFECTING BAEP RECORDING 
TECHNICAL FACTORS 
A. STIMULUS RATE 
 This is the number of clicks presented to the ear per second. The 
recommended rate is 10-40 clicks per second (In practice, the  stimulus 
rate used is an odd figure like 11.1/sec). This is done to lessen the 
polluting effects of the 50 hertz noise from electrical circuits. If the 
stimulus rate is such that 50 which is divisible by it, the sound stimulus is 
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rejected. Very high stimulus rates, say, 80 or 100 clicks per second, 
change the latency and amplitude of the BAEP waves. Usually, the 
amplitude decreases and the latency increases if the stimulus rate is very 
high. Increase in click rate increases the absolute latencies and decreases 
the amplitude of most of the BAEP waveforms. IPLs increase slightly at 
higher rates (Stockard et al.,1978&1979)146,147. But Chiappa et al.,1979 
showed that increasing click rate from 10/s to 30/s has no value. 
B. STIMULUS PHASE OR POLARITY 
The phase or polarity of the click stimulus is one of the factors 
which can affect the latency, amplitude and even morphology of the 
BAEP waveforms. The phase of the click stimulus may be two types, viz. 
condensation phase and rarefaction phase. The transducer which 
produces the click sound has a diaphgram which vibrates i.e., moves 
outwards and inwards to produce the sound. When the diaphgram moves 
initially outwards i.e., towards the ear drum, the phase is called 
condensation phase. When the diaphragm of the transducers first move 
inwards, i.e., in a direction away from the ear drum, it is called 
rarefaction phase.  For routine BAEP studies, use of the rarefaction phase 
is recommended because it produces better resolution of the BAEP 
waves. However, many neurologists use an alternating phase, that is, 
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rarefaction phase and the condensation phase alternating in close 
succession. This somewhat reduces the electrical and stimulus artifacts 
but at the same time reduces the sharpness of the BAEP wave peaks. The 
use of a condensation phase or even an alternating phase slightly increase 
the absolute latencies of the BERA waves I , II, III, IV (especially, if the 
patient has a frequency sensori- neural loss) as compared to that when a 
rarefaction phase is used. However the latency and amplitude of wave V 
is not much altered by the change in phase of sound stimulus. 
C.INTENSITY OF THE SOUND STIMULUS 
 For routine BAEP studies, the intensity of the click stimulus of 
60dB supra threshold is recommended, i.e., 60dB above the hearing 
threshold of the ear being tested. Some laboratories however perform the 
test at a slightly lower supra threshold, level say 40 or 50dB above 
threshold. Lowering the intensity of the click stimulus increases the 
absolute latencies and decreases the amplitude of the BERA waves. 
Stockard et al., in 1978146 reported that absolute latencies increase and 
amplitudes diminish with decrease in intensity of click stimulus by abou 
0.03 msec/dB. The first wave to be obscured by lowering the stimulus 
and intensity is usually wave I; wave V is the most stable and is the last 
wave to disappear when the stimulus intensity is gradually lowered. In 
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fact, the wave V is discernable even when the stimulus is just 10db above 
the behavioural threshold. Since the amplitude and latency of BAEP  
waves are dependent on the intensity of click sound for eliciting the 
Brainstem Auditory Evoked potentials, the neurotologist should always 
stick to using the same supra threshold stimulation not only in both ears 
of the same patient, but also in all patients such that the results are easily 
comparable. If the normal values of the latencies and amplitude in a 
particular laboratory has been setup, by using a 60dB supra threshold 
stimulation, then in all patients (in the laboratory) this 60dB supra 
threshold stimulus should essentially be used.  
D. BINAURAL/MONOAURAL STIMULATION 
 In clinical studies only a monoaural stimulation is recommended 
because monoaural abnormalities are common in neurologic disease and 
in binaural stimulation response from normal ear may mask the 
abnormality of waveform in abnormal ear (Stockard et al.,1978)146. So 
that only one ear at a time should be tested. Presenting the sound stimulus 
to both ears together (binaural) increases the amplitude of the wave III, 
IV,V but not wave I. 
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E. FILTER CHARACTERS OF THE BAEP MACHINE 
 The BAEP machine should be so adjusted that it records only 
between a fixed range of frequencies. The lower limit of this frequency 
range, called lower frequency filter should be 100Hz or 150Hz and the 
higher limit called the high frequency filter should be either 3000 or 
5000Hz. The high frequency is usually kept at 3000Hz. These are called 
filter settings and can be changed in the BAEP machine. Frequencies 
lower than 100Hz should be cut of such that EMG or EEG or other lower 
electrical noise is not able to contaminate the BAEP recording. 
Frequencies higher than 5000Hz should be cut off to reduce high 
frequency electrical noise artifacts. 
 To interpret the BAEP accurately and to compare with the 
normative data, the neurotologist should ensure that fixed or standard and 
correct filter settings have been used for BAEP recording. Altering the 
filter settings will change the amplitude ratios of the waves and introduce 
unwanted artifacts into the BAEP tracing. 
F. NATURE OF SOUND USED 
 For eliciting the BAEP response, the sound stimulus used is a click 
sound as already mentioned. The click sounds are generated as square 
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wave  pulses  each  of  which  are  of  0.1  milliseconds  of  duration.  When  
BAEP test is being done for neurological diagnosis, it is essential that all 
the BAEP waves are clearly recorded. Hence the sound stimuli (clicks 
only) are delivered at 50-60dB above hearing threshold since this evokes 
neat and robust easily recognizable wave peaks. When the BAEP is used 
for audiological purposes, sometimes pure tone sound stimulus (tone-
pips) is used. With tone-pips, the BAEP wave morphology is poor and 
the sensitivity is also much lesser. With click evoked BAEP, the BAEP 
threshold (appearance of a recognizable wave V) is within 10dB of the 
hearing threshold whereas with tone-pips evoked BAEP, the BAEP 
threshold is 25-35dB above the behavioural hearing threshold. 
 With all these specifications, it is futile to compare the BAEP test 
done at 30dB supra threshold using an alternating phase and a stimulus 
rate  of  81  Hz  with  that  done  at  60dB supra  threshold  with  a  rarefaction  
click phase and a stimulus rate of 11.1Hz. 
NON TECHNICAL FACTORS 
A. AGE OF THE PATIENT 
 In very young children, less than 2yrs of age, latencies are slightly 
prolonged even if the hearing is normal (Starr et al.,1976)143. BAEP 
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matures  to  adult  pattern  over  a  period  from  birth  to  the  age  of  18  –  
24months (Hecox andGalambos)51.The reason for this age related 
change is due to completion of myelination of the auditory neural 
pathway only by 2 yrs (Tarantino et al .,1988)155.There is an age related 
prolongation  of  latency  of   wave  I  but  not  of  other  waves  like  wave  III  
which shows that ageing is a peripheral process.  The IPL values 
especially III-V & I-V IPL which actually reflects the central conduction 
time does not show a significant change with increasing age (Costa et al 
.,1990)40.In old age patients of more than 65yrs, some increase of latency 
of wave V is observed. Older adults have longer I-V IPL by 0.1-0.15 ms 
compared to younger individuals (Nuwer et al.,1994)107. Hence 
normative data for these special groups of population should be 
separately worked out. 
B. GENDER OF THE PATIENT 
The BAEPs show significant differences between males and 
females. Absolute latency of wave V and wave I-V IPL are consistently 
prolonged by 0.15 to 0.2 milliseconds for 60-70dbSL stimulation 
intensities. The amplitude of the BAEP is significant in females (upto 40-
50%). These gender differences are seen in children only after 8yrs of age 
(Stockard et al., 1978)146. I – V IPL decreases by almost one second at 
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the time of menstrual periods. These differences between males and 
females are most probably related to the differences of their head size 
(corresponding to the thicker skulls and longer auditory pathway in 
males) and possibly also to their differences in core temperature, which 
tends to shorten IPL s.(Taghavy A & Losslein H)152 
Table 3.Gender differences in normal BAEP waveforms 
WAVES 
Taghavy&Losslein et al 
2006 
Pedrialli et al 2004 
Females Males Females Males 
I 
II 
III 
IV 
V 
I –III 
I – V 
III – V 
1.59 ± 0.09 
2.75± 0.12 
3.67 ± 0.15 
4.97 ± 0.17 
5.52 ± 0.15 
2.08 ± 0.13 
3.90 ± 0.19 
1.85 ± 0.14 
1.64 ± 0.16 
2.83 ± 0.19 
3.91 ± 0.20 
5.14 ± 0.25 
5.80 ± 0.20 
2.27 ± 0.20 
4.18 ±0.24 
1.90 ± 0.19 
1.44± 0.10 
 
3.56 ± 0.09 
 
5.32 ± 0.13 
2.12 ± 0.11 
3.88 ± 0.17 
1.75 ± 0.12 
1.42 ± 0.06 
 
3.61 ± 0.13 
 
5.54 ± 0.21 
2.18 ± 0.13 
4.11 ± 0.21 
1.93+ 0.14 
C. TEMPERATURE 
 With decreasing central body temperature, the latencies of the 
BAEPs are increased (Picton et al., 1982)112 (Stockard JJ)147. A 0.17 
increase  in  wave  V  latency  on  10 C reduction of body temperature is 
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reported. At 32.50C,  BAEP  waveforms  are  distinctly  abnormal  and  at  
270C the waveforms disappear. 
D. HYPOGLYCEMIA 
Hypoglycemia  increases  IPL  I-V  &  III-V  but  changes  in  wave  I  
latency was not significant (Kern et al., 1994)73 
E. DRUGS 
The  BAEPs  are  resistant  to  the  effect  of  drugs.  A  slight  
prolongation of wave V latency with barbiturates or  alcohol is attributed 
to lowering of body temperature. 
F. HEARING DISORDERS 
In peripheral hearing disorders the absolute latencies of all waves 
are increased with no change in IPLs an effect similar to that of decreased 
stimulus intensity (Chiappa K.H)36 . 
G. OBESITY 
Obesity prolongs absolute latencies of waves I, III and V but does 
not have any influence on interpeak latencies (Aanandha Subramaniam 
K et al)1. 
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H. HEIGHT 
Height does not influence the parameters of BAEP waveforms.  
PARAMETERS MEASURED IN BAEP 
Amplitude and latencies of waves I, II,III, IV &V and I-III, I-V 
&III-V IPLs were measured. 
ESTIMATION OF SERUM ZINC LEVELS 
Under strict aseptic precautions, blood samples were collected by 
means of venepuncture and the separated serum was stored in deep 
freezer at 200C.  Serum zinc  levels  were  estimated  in  the  Department  of  
Biochemistry, Institute of Child Health, Egmore, Chennai. 
PRINCIPLE 
Zinc in an alkaline medium reacts with Nitro-PAPS to form a 
purple colored complex. Intensity of the color complex formed is directly 
proportional to the amount of Zinc present in the sample. 
Zinc  + Nitro-PAPS  ======è  Purple Colored Complex in Alkaline  
   medium 
Normal reference values  :    60 – 120 micrograms / dl 
PHOTO NO. 3 
COLORIMETER AND SERUM SAMPLES 
 
 
 
 
 
 
 
 
 
 
 
 
ZINC KIT 
  
103 
 
 
 Contents of the kit   :    75  ml  of  the  kit  contains  60  ml  of  Buffer  
Reagent(L1), 15 ml of Color Reagent(L2) and Zinc Standard(200 
micrograms/dl) 
Reagent Preparation 
The color Reagent is poured into the bottle containing Buffer 
Reagent.  This  is  the  working  reagent  and  is  stable  for  2  weeks  when  
stored at 2-80C. 
PROCEDURE 
Wavelength / filter  :    570 nm / Yellow 
Temperature               :   R. T. 
Light Path                   :    1 cm 
Pipetting was done into clean dry test tubes labeled as Blank (B), 
Standard(S) and Test(T). 1 ml of working reagent and 0.05 ml of distilled 
water were added to test tube B, 1 ml of working reagent and 0.05 ml of 
zinc standard were added to test tube S and  I ml of working reagent and 
0.05  ml  of  serum  sample  were  added  to  test  tube  T.  The  contents  were  
mixed well and incubated at room temperature (250C) for 5 minutes. The 
absorbance of standard (Abs. S) & test sample(Abs. T) were measured 
against the Blank within 20 minutes. 
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CALCULATION 
Zinc in micrograms / dl     =     Abs. T / Abs. S     X   200 
STATISTICAL ANALYSIS 
Statistical analysis was done using the software SPSS version 21. 
1. Student’s T test was carried out to compare the means of variables 
between ADHD children and normal controls. 
2. The analysis of variance was worked out to find out if there was 
significant differences in zinc levels and BAEP parameters among 
the three ADHD subtypes. 
3. Pearson’s correlation coefficient was carried out to find the 
correlations between the serum zinc levels and BAEP in ADHD 
children. 
  
 Results  
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5.  RESULTS 
BAEP is an objective test to assess the functional integrity of 
auditory pathway and neurotransmission which is likely to be affected in 
ADHD  children.  In  the  present  study  various  BAEP  parameters  and  
serum zinc levels are compared between the control group of children 
and ADHD children. 
CHARACTERISTICS OF CONTROL AND STUDY GROUPS 
The parameters used for selection of study and control subjects are 
furnished in Table 4. Among the children selected for the study, the mean 
age of  the control  children was 7.67±1.47 and the mean age for  ADHD 
group was 7.66±1.52 both in within the range of   6 to 11 years. Among 
the ADHD children selected 10 belong to the combined type of ADHD 
and 10 each to the inattentive and hyperactive subgroups. The mean 
height of control children was 123.18±7.5 and that of ADHD children 
was 124.7±8.06. The mean weight for control children was 23.37±4.15 
while that of ADHD group was 24.38±4.33. The average BMI for control 
children was 15.27±0.82 and that of ADHD group was 15.56±0.90. Thus 
there was no significant difference between the control and ADHD group 
 Graph 1. Comparison of Age between control and ADHD children 
 
 
Graph 2.Comparison of   BMI between control and ADHD children 
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in terms of height, weight and BMI making the two groups well 
comparable. 
BMI was calculated using the formula weight in kg/height in cm2 and 
BMI percentile was compared between normal healthy children of same 
age and sex. 
BMI between 5th and 85th percentile is normal. 
BMI between 85th and 95th percentile is overweight. 
BMI < 5th percentile is underweight. 
BMI > 95th percentile is obese. 
The specific ENT examination which include examination of the 
auditory canal for wax and assessment of hearing ability by pure-tone 
audiometry was normal in both control and ADHD children. 
Table 4. Comparison of parameters (Mean ±SD) between control and 
ADHD children 
Sl. No Variables 
Normal 
children 
ADHD 
children 
P value 
1. Age (years) 7.67 ± 1.47 7.66 ± 1.52 0.97 
2. Weight (kg) 23.37 ± 4.15 24.38 ± 4.33 0.36 
3. Height (cms) 123.18 ± 7.5 124.7 ± 8.06 0.45 
4. BMI 15.27 ± 0.82 15.56 ± 0.90 0.19 
5. ENT Examination Normal Normal  
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SOCIO-ECONOMIC PROFILE 
Twenty-one out of the thirty ADHD children belonged to low 
socioeconomic group whereas the remaining nine children belonged to 
the middle class. Thus the prevalence of ADHD was found to be high in 
the lower socioeconomic group accounting to be about 70%. 
Graph 3.  Distribution of ADHD children among different  
socio-economic classes 
 
 
The random selection of ADHD children during the study period 
has given a prevalence of about 70% is concordant with the study 
conducted by Malhi P et al91 and several other studies. 
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BRAINSTEM AUDITORY EVOKED POTENTIAL (BAEP) 
VARIABLES 
          The variables pertaining to BAEP between normal and ADHD 
children are furnished in Tables 5 - 8. 
Table 5. Mean ± SD of Absolute wave latencies between normal and 
ADHD children (RIGHT EAR) 
WAVE NORMAL ADHD T TEST P VALUE 
I 1.5 ± 0.06 1.49 ± 0.06 0.65 0.52 
III 3.54 ± 0.18 3.67 ± 0.23 2.44 0.02 
V 5.39 ± 0.17 5.49 ± 0.19 2.29 0.02 
wave III (p = 0.02) : significant; wave V (p = 0.02) : significant 
wave I (p = 0.52) : not significant. 
Table 6. Mean ± SD of Interpeak latencies (IPLs) between normal 
and ADHD children (RIGHT EAR). 
IPL NORMAL ADHD T VALUE P VALUE 
I – III 2.039 ± 0.19 2.18 ± 0.25 2.46 0.01 
I – V 3.89 ± 0.18 4.01 ± 0.22 2.31 0.02 
III – V 1.85 ± 0.09 1.83 ± 0.23 0.38 0.70 
IPL I – III (p = 0.01) : significant ; IPL I – V (p = 0.02) : significant ; 
IPL III – V (p = 0.70) : not significant. 
Graph 4. Comparison of Absolute latencies of Right ear between 
normal and ADHD children 
 
 
Graph 5. Comparison of  Interpeak latencies of  Right ear between 
normal and ADHD children 
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Table 7. Mean ± SD of Absolute wave latencies between normal and 
ADHD children (LEFT EAR). 
WAVE NORMAL ADHD T VALUE P VALUE 
I 1.34 ± 0.32 1.44 ± 0.16 1.52 0.13 
III 3.43 ± 0.27 3.67 ± 0.29 3.31 0.01 
V 5.35 ± 0.32 5.55 ± 0.40 2.09 0.04 
 
wave  III (p = 0.01) : significant ; wave V (p = 0.04) : significant ; 
wave I (p = 0.13) : not significant. 
Table 8. Mean ± SD of Interpeak latencies(IPLs)  between normal 
and ADHD children (LEFT EAR). 
IPL(ms) NORMAL ADHD T VALUE P VALUE 
I – III 2.09 ± 0.49 2.23 ±0.33 59.30 0.20 
I – V 4.01 ± 0.39 4.10 ± 0.45 0.80 0.42 
III – V 1.92 ± 0.42 1.87 ± 0.36 0.41 0.68 
  
I  –  III  IPL  (p  =  0.20)  :  not  significant;  I  –  V  IPL  (p  =  0.42)  :  not  
significant;  
III – V IPL (p = 0.68) : not significant. 
 
Graph 6. Comparison of absolute latencies of Left ear between 
normal and ADHD children 
 
 
 
 
 
 
 
Graph 7. Comparison of Interpeak latencies of Left ear between 
normal and ADHD children 
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SERUM ZINC LEVELS 
        The difference in the mean values of serum zinc levels between 
normal and ADHD children are given in Table 9. 
Table 9. Mean ± SD of Serum Zinc levels between normal and ADHD 
children. 
GROUPS 
SERUM ZINC 
LEVELS(μg/dl) 
T VALUE P VALUE 
NORMAL 107.27 ± 28.13  
2.53 
 
0.01 ADHD 88.4 ± 29.55 
 
P value : 0.01 (significant) 
Analysis of Variance of Serum Zinc levels and BAEP variables 
among three ADHD subtypes 
             Analysis of Variance was done for serum zinc levels and various 
BAEP variables among the three ADHD subtypes namely predominantly 
inattentive, combined and hyperactive-impulsive types. Significant 
variation was found for serum zinc levels among the three subtypes of 
ADHD whereas no significance was attached to difference in BAEP 
  
Graph 8.Comparison of Serum zinc levels between normal and 
ADHD children 
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variables among these three subtypes. The results of the analysis of 
variance are furnished in the Tables 10 &11. 
Table 10.ANOVA for serum zinc levels among the three ADHD 
subtypes 
Source of 
variation 
Sum of 
squares 
df 
Mean 
square 
F statistics 
Between 
groups 
7133.6 2 3566.8  
5.29541 
Within 
groups 
18186.2 27 673.56 
  P value = 0.01 (significant) 
Table  11.ANOVA  for  IPL  I  –  III  of  RIGHT  EAR  among  three  
ADHD subtypes 
Source of 
variation 
Sum of 
squares 
df 
Mean 
square 
F statistics 
Between 
groups 
0.10374 2 0.05187  
0.8494 
Within 
groups 
1.6488 27 0.06107 
P value = 0.44 (not significant) 
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          Analysis of variance among three ADHD subtypes were not 
significant for absolute nor interpeak latencies of right and left ear. 
Correlation of BAEP variables with serum zinc levels 
Various BAEP variables were correlated with serum zinc levels 
using Pearson’s correlation coefficient and the results are furnished in 
Tables 12 and 13. Correlation of serum zinc levels with BAEP variables 
showed a weak positive correlation on both right and left ears which is 
not significant. 
Table 12.Correlation of  BAEP variables of right ear with serum zinc 
levels 
BAEP VARIABLES SERUM ZINC LEVELS 
WAVE III                                        r 
                                                         P 
0.138 
0.466 
IPL I – III                                         r 
                                                         P 
0.188 
0.321 
WAVE V                                         r 
                                                         P 
0.016 
0.932 
IPL I – V                                          r 
                                                         P 
0.084 
0.658 
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Table 13.Correlation of BAEP variables of left ear with serum zinc 
levels 
BAEP VARIABLES SERUM ZINC LEVELS 
WAVE III                                      r 
                                                       p 
0.158 
0.405 
IPL I – III                                       r 
                                                        p 
0.255 
0.174 
WAVE V                                        r 
                                                        p 
0.199 
0.293 
IPL I – V                                         r 
                                                        p 
0.258 
0.168 
 
  
 Discussion 
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6.  DISCUSSION 
             All the ADHD children included in the present study had fulfilled 
the DSM IV criteria and Brainstem Auditory Evoked Potentials were 
recorded and the results were evaluated for assessing the central auditory 
processing and functional integrity of auditory pathway. 
CHARACTERISTICS OF STUDY SUBJECTS 
             The mean age of ADHD children included in the present study 
was 7.665 ± 1.52 years who were in the range of 6 – 11 years.  
             This is in accordance with the mean age of ADHD children in the 
study done by    Hannan Azzam et al 56 (7.4 ±2yrs). The average age of 
ADHD children in the study conducted by A Puente et  al2 was about  9 
yrs  whereas  the  average  age  of  control  group  was  22  yrs  and  this  may  
provoke a doubt about the prolongation of the absolute and interpeak 
latencies as due the differences in age among the controls and ADHD 
children. But in the present study there was no significant age differences 
among the control and ADHD group and therefore, it can be inferred that 
the changes in the BAEP waveforms which are evidences of defects in 
the central auditory processing and functional integrity of auditory 
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pathways in the ADHD children are perse due to the disorder rather than 
due to age related changes. Aanandha  Subramaniam  K  et  al1 have 
shown that obesity prolongs the absolute latencies of waves I, III and V 
and since in the present study the height, weight and BMI of the ADHD 
children were within the normal range (between 5th percentile and 85th 
percentile) and also as there was no significant differences among control 
and ADHD children, it could be inferred that the changes in the absolute 
latencies of both ears are due to ADHD rather than BMI related changes. 
BRAINSTEM AUDITORY EVOKED POTENTIAL 
              The present study deals with the changes in BAEP due to 
Attention Deficit Hyperactivity Disorder.  A Puente  et  al 2 have shown 
that there is defective central auditory processing and asymmetric 
conduction of auditory stimuli in ADHD. Hence ADHD children with 
associated specific learning disability (SLD), autism and other 
neurological disorders who may also  have  defective auditory processing 
were excluded from the study. The main parameters that were considered 
for detecting abnormal auditory processing were absolute wave latencies 
and interpeak latencies.   
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WAVE I 
              The mean values of wave I in ADHD children were 1.49± 0.06 
and 1.44 ± 0.16 milliseconds respectively in right and left ears. There is 
no significant difference (p = 0.52 and 0.14 in right and left ears 
respectively) from the latency of wave I recorded in normal children  
(1.5 ±0.06 and 1.34 ± 0.32 respectively). This is consistent with the study 
conducted by Hannan Azzam et al56 in which there was no significant 
difference in absolute latencies of wave I between ADHD and control 
groups( 1.4 ± 0.1 and 1.4 ± o.1; p value : 0.6 in right ear & 1.3 ± 0.1 and 
1.4 ± 0.1 ; p value :0.2 in left ear) in ADHD and control children 
respectively. Similar findings were also recorded in studies conducted by 
Neelam Vaney et al105, A Puente et al 2 and Lahat et al79. If wave I is 
delayed , it indicates that there is a cochlear pathology and since in the 
present study as there is no significant prolongation of  wave I latency of 
ADHD children when compared to normal children we can infer that 
there is no cochlear i.e; peripheral pathology in ADHD children. 
WAVES III AND V 
The mean values recorded in ADHD children were 3.67 ± 0.23 and 
3.67 ± 0.29 for wave III in right and left ears respectively and 5.497 ± 
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0.19 and 5.546 ± 0.40 for wave V in right and left ears respectively. 
These values were significantly higher than those recorded in controls. 
This is consistent with the study conducted by Hannan  Azzam  et  al56 
who showed statistically significant prolongation of wave III and V 
latencies in ADHD children. 
A Puente et al2 showed prolonged latencies of waves III and V in 
children with ADHD. Lahat et al79 showed prolonged wave V latency in 
males and wave III and wave V latencies in females. The present study 
was conducted only considering ADHD boys and so the above findings 
of any difference among genders could not be shown. Neelam  
Vaney et al105  has  shown  that  there  was  no  statistically  significant  
prolongation of wave III and V latencies in ADHD children. Though not 
statistically significant there was a minimal prolongation of wave III and 
V latencies in ADHD children when compared to controls. 
INTERPEAK LATENCIES I – III and I – V  
The mean values of I – III IPL were 2.18 ± 0.25 and 2.23 ± 0.33 
and I – V IPL were 4.01 ± 0.22 and 4.10 ± 0.45 in right and left ears 
respectively of ADHD children. These were statistically significant in 
right ear (p value 0.01for IPL I-III and 0.02 for I-V IPL) but was not 
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statistically significant in left ear (p value 0.20 for IPL I-III and 0.42 for 
I-V IPL). Though not statistically significant, there was a mild 
prolongation of  I-III and I-V IPLs in left ear. 
                 Hannan Azzam et al56 found statistically significant 
differences in both I-III and I-V IPLs in both right and left ears 
(I-III IPL 2.1±0.2 and 2.2±0.2 and I-V IPL 4±0.3 and 3.8±0.4 in right and 
left ears respectively. The reason for the absence of significant 
prolongation in the left ear in the present study may be due to asymmetric 
conduction of auditory stimuli in both the ears. 
                A Puente et al2 showed prolonged I-III and I-V IPLs in ADHD 
children compared to controls. Lahat  et  al79 showed significant 
prolongation of both I-III and I-V IPLs in females whereas ADHD boys 
had prolongation of  I-V IPL alone.                
                 The statistically significant prolongation of the absolute 
latencies III and V as well as interpeak latencies I-III and I-V suggest 
synaptic delay due to abnormal brainstem neurotransmission and defect 
in central auditory processing which leads to the disruption of functional 
integrity of the auditory pathways. 
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                In contrast , Neelam Vaney et al105 showed that there was no 
significant prolongation of  I-III or I-V IPL in ADHD children compared 
to controls. Though not statistically significant, however there was a mild 
prolongation of both I-III and I-V IPLs in ADHD children compared to 
controls. The reason for this contrasting finding may be due to the 
difference in size of sample in the contrasting study than in the present 
study and also due to the variation in the type of study subjects selected. 
The type of ADHD involved in the contrasting study was of combined 
type where as in the present study 10 each from the three subtypes of 
ADHD were selected. Preterm children were excluded from the 
contrasting study whereas they were included in the present study. The 
other reasons may be due to variation in standardization of the equipment 
and BAEP settings used. In the present study, 2000 click stimuli were 
delivered at the rate of 11.1 Hz at 80 dB whereas in the contrasting study 
1000 click stimuli were delivered at the rate of 10 Hz 60 dB above the 
hearing threshold. One another reason could be the method of analysis. 
The averages for right and left ear were taken and analyzed in the 
contrasting study whereas the right and left ears were analyzed separately 
in the present study and also in the study which is in agreement with the 
present study (Hannan Azzam56 et al). 
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III – V IPL 
           There is no statistically significant difference in III-V IPL of both 
ears in ADHD children compared to normal children (p values 0.70 and 
0.67 in right and left ears) of ADHD children respectively. This is in 
accordance with similar studies (Hannan Azzam 56et  al  ,  A   Puente2  
et al, Lahat 79 et al and Neelam Vaney 105 et al).  
The prolongation in absolute latencies of waves III and V and IPLs 
I-III  and I-V suggest an objective evidence of subclinical defect in 
central auditory processing. The underlying defect may be due to 
variation in the synaptic function, axonal growth and myelination. 
Normal perception requires appropriate timing of stimulus encoded in the  
auditory brainstem structures. Prolonged latencies of the above waves 
suggest delay in the appropriate timing of the stimulus in reaching the 
auditory brainstem structures. A defect in the auditory processing of 
sequential  information  is also reported among these children. Though 
the present study throws light onto auditory conduction abnormality as a 
factor contributing to the attention deficit, further studies involving larger 
samples of subjects may provide better elucidation and strengthening of 
the above facts shown in the present study. 
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SERUM ZINC LEVELS 
             The serum levels of zinc were significantly lower in ADHD 
children (p value 0.01) with the mean values of 88.4 ± 29.55μg/dl when 
compared to the controls with mean values of 107.27 ± 28.13μg/dl. This 
is consistent with several other similar studies which has shown lower 
serum zinc levels in ADHD children compared to controls. 
             Kozielec 76 et al in a study among ADHD children in Poland 
showed that serum zinc levels were significantly lower in ADHD 
children(p < 0.001) when compared to controls. 
            Toren 161 et al in Israel had reported significantly lower serum 
zinc levels in a group of 39 boys and 4 girls with ADHD in the age group 
of 6-16 years compared to 28 age matched controls. This age group is  
nearly similar to age of the ADHD children in the present study. 
           Bekaroglu20 et al in Turkey recorded low mean serum zinc levels 
in ADHD children(60.6 ± 9.9μg/dl when compared to controls(105.8 ± 
13.2μg/dl). 
           Starobrat-Hermelin142 et  al  in Poland reported iron, copper, 
magnesium and calcium deficiencies in addition to zinc deficiency by 
analyzing serum, red blood cells and hair of ADHD children. 
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             Bettger 22 et  al  has shown that zinc is essential for maintaining 
the neuronal structure as it is essential for the metabolism of PUFA which 
are the building blocks of neuronal membranes by acting as a cofactor for 
the enzyme delta-6-desaturase. Toren 161 et  al has shown that zinc is a 
cofactor for metabolism of dopamine which is involved in the 
pathogenesis  of  ADHD  and  so  may  contribute  to  the  abnormal  central  
auditory processing in ADHD by affecting appropriate 
neurotransmission. The main defect in ADHD may be in myelination of 
neurons, neuronal growth and abnormal neurotransmission the 
pathogenesis of which may be contributed by zinc deficiency in ADHD 
children found in the present study. 
            Analysis of variance among the three ADHD subtypes showed 
significant  differences( p value 0.01) among the inattentive, hyperactive-
impulsive  and  combined  subtypes  of  ADHD  in  terms  of  serum  zinc  
levels. 
            Arnold 12 et al 2005 in an American study reported that low 
serum zinc levels negatively correlated (Sr = -45 and p = 0.004) with 
parent and teacher rated inattention but not with hyperactivity and 
impulsivity. But another study by Bilici et al28 in turkey showed that low 
serum zinc levels correlated with hyperactivity but not with inattention. 
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           Analysis of variance among the three ADHD subtypes did not 
show significant variation in terms of BAEP waveforms. 
CORRELATION OF BAEP VARIABLES 
          There was no significant correlation between serum zinc levels and 
various BAEP parameters of ADHD children. All the BAEP parameters 
showed weak positive correlation with serum zinc levels. But there 
should be negative correlation as ADHD children will have low serum 
zinc levels which leads to prolonged absolute and interpeak latencies of 
BAEP waveforms as zinc contributes to the effective neurotransmission 
due to its cofactor role in the metabolism of dopamine implicated in the 
pathogenesis of ADHD and also it is implicated in the metabolism of 
PUFA which are the building blocks of neuronal membranes. 
          The reasons for the contradictory weak positive correlation 
between serum zinc levels and BAEP waveforms in the present study 
may be attributed to the minimum sample size and variations among the 
ADHD children. 
             
                  
 Conclusion 
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7.  CONCLUSION 
It has been suggested that asymmetrical auditory stimuli 
conduction in the brainstem auditory structures plays a role in the 
pathogenesis of ADHD and in the present study the above fact is proved 
beyond doubt by the prolongation of various absolute latencies and 
interpeak latencies of the BAEP waves.  
The absolute latency of waveform points out to time of conduction 
of auditory stimulus along the various components of auditory pathway 
and interpeak latencies show neuronal conduction in segments of 
auditory pathway.  
           Decreased serum zinc levels are seen in children with ADHD. 
Zinc contributes to effective neurotransmission in the auditory pathway 
by acting as a cofactor for dopamine involved in the pathogenesis of 
ADHD.  It  also  acts  as  building  blocks  of  neuronal  membranes  as  it  is  
involved in the metabolism of PUFAs which constitute important 
components of neuronal membranes. So zinc supplementation may 
benefit ADHD children by correcting the altered neurotransmission 
which could be evaluated by BAEP study, which is a non-invasive 
neurophysiological tool which provides useful information about the 
central auditory processing. Further studies are recommended to elucidate 
and strengthen the above facts. 
 Summary 
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8.  SUMMARY 
The present study was conducted to evaluate the functional 
integrity of auditory pathway and central auditory processing by 
Brainstem Auditory Evoked Potentials and to determine the variation of 
serum zinc levels and BAEP waveforms among the three ADHD 
subtypes. 
30 ADHD children, 10 each from each of the three ADHD 
subtypes and 30 normal children were included in the study and BAEPs 
were recorded. Most of the ADHD children showed prolonged absolute 
latencies of waves III and V and IPLs I – III and I – V when compared to 
age  and  BMI  matched  controls.  Thus  the  results  indicate  that  there  is  a  
defective central auditory processing in ADHD. 
Decreased serum zinc levels were seen in ADHD children 
compared to controls and this indicates the role of zinc in the 
pathogenesis of ADHD. Analysis of variance for serum zinc levels 
among the three subtypes show that there are significant differences 
among the three groups in zinc levels. 
 With the above results, it is proved that central auditory processing 
is defective in ADHD and zinc supplementation may be beneficial in 
ADHD children 
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INFORMED CONSENT FORM 
Title of the study: “Evaluation of Brainstem auditory evoked 
potential and serum zinc levels in children with Attention Deficit 
Hyperactivity Disorder” 
Name of the Participant:  
Name of the Principal Investigator:  DR.J.Anitha Ponmalar 
Name of the Institution:  
          Institute of Physiology and Experimental Medicine, 
          Madras Medical College and Institute of Child Health, 
          Egmore, Chennai-8. 
 
Documentation of the informed consent 
I _____________________________ have read the information in 
this form (or it has been read to me). I was free to ask any questions and 
they have been answered. I am the guardian of the child   and, exercising 
my free power of choice, hereby give my consent for my child to be 
included as a participant in “Evaluation of Brainstem Auditory Evoked 
Potential   and serum Zinc  levels   in children with Attention Deficit  
Hyperactivity Disorder” 
1. I have read and understood this consent form and the information 
provided to me. 
2.  I have had the consent document explained to me. 
3.  I have been explained about the nature of the study. 
4.  I have been explained about my child’s rights and responsibilities 
by the investigator. 
5.  I have informed   the investigator of all the treatments my child is  
taking or have taken in the past ________ months including any 
native (alternative) treatment. 
 
 6. I have been advised about the risks associated with my child’s 
participation in this study. 
7.  I agree to cooperate with the investigator and I will inform him/her 
immediately if my child suffers unusual symptoms.  
8.  My child   has  not participated in any research study within the 
past _________month(s).  
9.  I  am aware  of  the  fact  that  I  can  opt  out  of  the  study  at  any  time  
without having to give any reason and this will not affect my 
child’s future treatment in this hospital.  
10.  I am also aware that the investigator may terminate my child’s 
participation  in  the  study  at  any  time,  for  any  reason,  without  my 
consent.  
12.  I hereby give permission to the investigators to release the 
information obtained from my child as result of participation in this 
study to the sponsors, regulatory authorities, Govt. agencies, and 
IEC. I understand that they are publicly presented. 
13. I have understood that my child’s identity will be kept confidential 
if my data are publicly presented. 
14.  I have had my questions answered to my satisfaction. 
15.  I have decided my   child   to be in the research study. 
I  am aware that  if  I  have any question during this  study,  I  should 
contact the investigator. By signing this consent form I attest that the 
information given in this document has been clearly explained to me and 
understood by me, I will be given a copy of this consent document. 
  
For adult participants: 
 
Name and signature / thumb impression of the participant (or legal 
representative if participant incompetent) 
 
Name _________________________ Signature_________________  
 
Date________________ 
 
Name and Signature of impartial witness (required for illiterate 
patients): 
Name _________________________ Signature_________________  
 
Date________________ 
 
Address and contact number of the impartial witness: 
 
Name and Signature of the investigator or his representative 
obtaining consent: 
 
Name _________________________ Signature_________________  
 
Date________________ 
 
 
 
INFORMATION TO PARTICIPANTS 
Investigator:   DR.J.Anitha Ponmalar 
Name of Participant: 
Title: 
Your child is invited to take part in this research/ study 
/procedures. The information in this document is meant to help you 
decide whether or not  your child to take part. Please feel free to ask if 
you have any queries or concerns. 
Your child is  asked to participate in this study being conducted in          
          Institute of Physiology and Experimental Medicine, 
          Madras Medical College and Institute of Child Health, 
          Egmore, Chennai – 8. 
 
What is the Purpose of the Research? 
Attention Deficit Hyperactivity Disorder (ADHD)  is one of the 
most common psychiatric disorders of childhood with a prevalence rate 
of  5-8%. Three subtypes have been identified in the Diagnostic and 
Statistical  Manual    (DSM-1V)   according  to  the  constituent  symptom  
profiles of  inattention and hyperactivity/impulsivity. The combined 
subtype is the most prevalent (61%) compared to inattentive (30%) and 
hyperactive type(9%).Defects in midbrain dopamine systems were 
recently implicated in the pathogenesis  of ADHD.Convergent data from 
neuroimaging, neuropsychology and neurochemical studies pointed out 
involvement of frontostriatal network as a likely contributor to 
pathophysiology of ADHD. ADHD is characterised by the impact of 
abnormal signals carried by midbrain dopamine system on frontal brain 
areas that implement cognitive control.  
  
The Study Design 
Thirty children with ADHD  will be selected for the study. 
Study Procedures 
The study involves assessment of Brainstem auditory evoked 
potential and serum zinc levels. 
Your child  will be required to visit the hospital once during the 
study. 
5ml  of  blood  will  be  collected  simultaneously  during  the  study.  
Blood collection 
Involves   prick with a needle and syringe. 
In addition, if you notice any physical or mental changes in your 
child , you must contact the persons listed at the end of the document.  
Your child may have to come to the hospital (study site) for 
examination and investigations apart from the  scheduled visits, if 
required. 
Possible Risks to your child - Nil 
Possible benefits to your child- Zinc deficiency and hearing disability if 
present can be diagnosed at an early stage so that proper intervention can 
be taken. 
Possible benefits to other people 
The result of the research may provide benefits to the society in 
terms of advancement of medical knowledge and/or therapeutic benefits 
to future patients.  
Confidentiality of the information obtained from your child 
You have the right to confidentiality regarding the privacy of your 
medical information (personal details, results of physical examinations, 
investigations, and your medical history). By signing this document, you 
will be allowing the research team investigators, other study personnel, 
sponsors, IEC and any person or agency required by law like the Drug 
Controller General of India to view your child’s  data, if required. 
The information from this study, if published in scientific journals 
or presented at scientific meetings, will not reveal your identity. 
How will your decision to not participate in the study affect you? 
Your decisions to not   to participate in this research study will not 
affect your child’s medical care or your relationship with investigator or 
the  institution.  Your  doctor  will  still  take  care  of  your  child    and  your  
child  will not lose any benefits to which you are entitled. 
  
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have 
the  right  to  withdraw  from  this  study  at  any  time  during  course  of  the  
study without giving any reasons. 
However, it is advisable that you talk to the research team prior to 
stopping the treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PROFORMA 
1. Name : 
2. Age: 
3. Sex: 
4. Address : 
5.         Complaints/duration: 
6. History of present illness: 
7. History of any hearing problem ? 
8. Past history: 
9. History of any drug intake 
10. History of associated illness: 
11. Developmental history: 
12.         Family History of ADHD or other psychiatric illness 
  
CLINICAL   EXAMINATION 
General examination: 
Vitals: 
Pulse rate: 
Respiratory rate: 
 
Anthropometry: 
Ht : 
Wt : 
 
Systemic examination: 
Cardiovascular system: 
Respiratory system: 
Gastrointestinal system: 
Central nervous system: 
 
ENT Examination : 
Examination of external ear 
Otoscopic examination 
Tuning fork tests 
Pure tone Audiometry 
 
IQ Assessment 
 
Serum Zinc levels 
 Master  Chart 
μg/dl
SL NO AGE WT HT BMI WAVE I WAVE III WAVE V IPL I-III IPL I-V IPL III-V WAVE I WAVE III WAVE V IPL I-III IPL I-V IPL III-V Zn LEVELS
1 6 20 116 14.8 1.44 3.52 5.51 2.08 4.07 1.99 1.23 3.71 5.58 2.49 4.35 1.86 131
2 7 21.5 120 15 1.46 3.49 5.4 2.03 3.94 1.91 1 3.36 5.64 2.36 4.64 2.27 106
3 6 19.5 115 14.8 1.49 3.55 5.49 2.06 4 1.94 1.56 3.4 5.75 1.84 4.19 2.35 150
4 8 24 125 15.4 1.53 3.57 5.3 2.04 3.77 1.73 1 3.78 5 2.78 4 1.22 102
5 8 25 125.4 15.9 1.5 3.5 5.48 2 3.98 1.98 1.33 3.37 4.9 2.05 3.58 1.53 120
6 7 21 119.5 14.7 1.52 3.48 5.29 1.96 3.77 1.81 1.36 3.11 5.15 1.75 3.79 2.04 149
7 11 32 139 16.6 1.47 3.46 5.28 1.99 3.88 1.82 1.51 3.3 5.28 1.79 3.76 1.98 103
8 9 27 131 15.7 1.7 3.3 5.3 1.6 3.6 2 1.48 3.41 5.08 1.94 3.6 1.66 144
9 8 23.5 124 15.3 1.49 3.48 5.4 1.99 3.91 1.92 1 4.03 5.35 3.03 4.35 1.33 111
10 10 31 136 16.8 1.5 3.51 5.39 2.01 3.89 1.79 1 3.5 5 2.5 4 1.5 119
11 6 20.5 115.5 15.4 1.46 3.47 5.29 2.01 3.83 1.82 1 3.03 5 2.03 4 1.97 125
12 8 23 124.5 14.8 1.48 3.49 5.36 2.09 3.96 1.87 1.29 3.35 5 2.06 3.71 1.65 170
13 7 22 119.2 15.5 1.5 3.55 5.31 2.05 3.81 1.76 1.59 3.59 5.37 2 3.79 1.79 67
14 6 20 114.8 15.1 1.49 3.53 5.3 2.04 3.81 1.77 1.07 3.62 5.28 2.55 4.2 1.65 128
15 10 32 136 17.3 1.5 3.51 5.33 2.01 3.83 1.82 1.59 3.16 5.16 1.57 3.58 2 75
16 11 32.5 140 16.3 1.48 3.5 5.39 2.02 3.91 1.89 1.07 3.55 5.75 2.48 4.67 2.2 60
17 8 22.4 121.8 15.14 1.7 3.47 5.21 1.77 3.51 1.74 1 3.46 5.3 2.46 4.3 1.84 88
18 8 22 123 14.6 1.46 3.49 5.3 2.03 3.84 1.81 1.64 3.04 5.81 1.4 4.17 2.77 54
19 7 21.5 119.3 15.14 1.52 3.53 5.31 2.01 3.79 1.78 1.86 3.45 5.35 1.59 3.49 1.9 133
20 9 27.5 131 16 1.49 3.54 5.3 1.95 3.81 1.76 1.65 3.58 5.1 1.93 3.45 1.53 89
21 7 20.8 119.8 14.44 1.5 3.53 5.32 2.03 3.82 1.79 1.36 3.96 5.34 2.6 3.98 1.37 121
22 6 19 115 14.4 1.44 3.51 5.34 2.07 3.9 1.84 1 3.69 5.11 2.69 4.11 1.43 117
23 7 21 120 14.6 1.47 3.45 5.29 1.98 3.82 1.84 1.49 3.25 5.9 1.76 4.41 2.65 100
24 6 19.5 115.4 14.66 1.51 4.2 6 2.69 4.49 1.8 1.87 3.06 5.08 1.19 3.2 2.01 101
25 7 22 119 15.54 1.46 3.45 5.28 1.99 3.82 1.83 1.6 3.81 5.89 2.21 4.29 2.08 114
26 8 24 124.2 15.79 1.52 3.53 5.51 2.01 3.99 1.98 0.73 3.33 5.55 2.6 4.83 2.23 97
27 9 28 132 16.09 1.49 4.12 5.8 2.63 4.31 1.68 1.29 3.34 5.01 2.05 3.73 1.67 84
28 7 20 119.7 14 1.46 3.46 5.3 2 3.84 1.84 1.64 3.21 5.41 1.58 3.78 2.2 100
29 7 19.5 118 14 1.48 3.47 5.33 1.99 3.85 1.86 1.99 3 5.99 1.01 4 2.99 61
30 6 19.5 116.2 14.4 1.52 3.56 5.6 2.04 4.08 2.04 1.05 3.5 5.46 2.45 4.41 1.96 99
MASTER CHART FOR CONTROL CHILDREN
LATENCY RT EAR (ms) LATENCY LT EAR (ms)
μg/dl
S NO AGE WT HT BMI WAVE I WAVE III WAVE V IPL I-III IPL I-V IPL III-V WAVE I WAVE III WAVE V IPL I-III IPL I-V IPL III-V Zn LEVELS
1 6 20 115.5 15.03 1.44 3.71 5.51 2.27 4.07 1.8 1.39 3.7 5.49 2.31 4.1 1.79 105
2 8 25 128 15.34 1.46 3.78 5.57 2.32 4.11 1.79 1.48 3.45 5.46 1.98 3.99 2.01 95
3 10 32.5 138 17.1 1.45 3.73 5.55 2.28 4.09 1.82 1.69 3.69 5.36 2 3.68 1.68 54
4 6 21 116 15.56 1.7 3.2 5.1 1.5 3.4 1.9 1.26 3.99 5.76 2.73 4.5 1.77 41
5 7 23 121 15.75 1.45 3.75 5.49 2.3 4.04 1.74 1.25 4 5.99 2.75 4.74 1.99 111
6 9 28 132 16.09 1.47 3.3 5.58 1.83 4.11 2.28 1.36 3.1 4.86 1.74 3.5 1.76 60
7 7 21 120.5 14.49 1.46 3.74 5.56 2.28 4.1 1.82 1.61 3.45 4.94 1.84 3.33 1.49 87
8 11 30.8 139 15.96 1.48 3.8 5.57 2.32 4.09 1.77 1.36 3.19 5 1.82 3.64 1.81 102
9 6 19.5 115 14.8 1.5 3.15 5.7 1.65 4.2 2.55 1.58 3.98 5.98 2.4 4.18 2 92
10 9 29 132.5 16.48 1.46 3.84 5.6 2.38 4.14 1.76 1.68 3.73 5 2.05 3.33 1.27 55
11 7 22.5 121 15.41 1.6 3.75 5.4 2.15 3.8 1.65 1.3 3.5 5.08 2.2 3.78 1.58 70
12 8 24 127 15 1.47 3.8 5.53 2.33 4.06 1.73 1.3 4.1 6.02 2.8 4.72 1.92 119
13 6 20.5 116.5 15.07 1.49 3.2 5.59 1.71 4.1 2.39 1.4 3.4 5.9 2 4.5 2.5 125
14 7 22 122 14.77 1.45 3.78 5.58 2.33 4.13 1.8 1.41 3.51 5.7 2.1 4.29 2.19 110
15 9 30 133 17 1.5 3.4 5 1.9 3.5 1.6 1.19 3.99 5.98 2.8 4.79 1.99 109
16 7 21 122 14.09 1.46 3.79 5.58 2.33 4.12 1.79 1.09 3.5 5.3 2.41 4.21 1.8 134
17 8 25.5 127 15.83 1.44 3.7 5.5 2.26 4.06 1.8 1.45 4 6 2.55 4.55 2 104
18 6 19 115 14.61 1.5 3.82 5.65 2.32 4.15 1.83 1.53 3.71 5.51 2.19 3.99 1.8 98
19 6 20.4 115 15.45 1.47 3.8 5.6 2.33 4.13 1.8 1.37 3.99 6.15 2.62 4.78 2.16 101
20 8 24 126 15.09 1.49 3.65 5 2.16 3.51 1.35 1.5 3.45 5.25 1.95 3.75 1.8 130
21 7 22.5 121 15.41 1.46 3.74 5.53 2.28 4.07 1.79 1.7 3.68 5.15 1.98 3.45 1.48 81
22 8 26 128 15.85 1.52 3.77 5.56 2.25 4.04 1.79 1.25 3.29 5.25 2.04 4 1.96 44
23 6 20 115.5 15.04 1.51 3.4 5.1 1.89 3.59 1.7 1.46 3.98 5.14 2.52 3.67 1.16 68
24 9 32 133 18.07 1.46 3.8 5.6 2.34 4.14 1.8 1.73 3.75 5.8 2.02 4.08 2.05 39
25 7 23.5 122 15.77 1.49 3.89 5.58 2.4 4.09 1.69 1.55 3.96 5.99 2.41 4.44 2.03 79
26 11 30 140 15.31 1.45 3.72 5.54 2.27 4.09 1.82 1.58 3.8 5.59 2.22 4.01 1.79 139
27 6 19.8 114 15.23 1.6 4.15 5.8 2.55 4.2 1.65 1.48 3.7 6 2.23 4.52 2.3 103
28 10 33 138 17.37 1.46 3.51 5.49 2.05 4.03 1.98 1.33 3.5 5.75 2.17 4.42 2.25 38
29 7 21.5 121 14.73 1.45 3.73 5.53 2.28 4.08 1.8 1.48 3.09 5.91 1.61 4.44 2.83 61
30 8 24.3 126.5 15.19 1.48 3.74 5.54 2.26 4.06 1.8 1.33 3.87 5.08 2.55 3.75 1.2 98
MASTER CHART FOR ADHD CHILDREN
LATENCY RT EAR (ms) LATENCY LT EAR (ms)
 KEY TO MASTER CHART 
 
Ht     - Height 
Wt    - Weight 
BMI                        -         Body Mass Index 
IPL                          -         Interpeak latency 
Zn                            -         Zinc 
 
 
 
 
 
 
